FeatureID,Name,Formula,MW,KEGG Pathways,Metabolika Pathways,name4plot,C,H,N,O,S,P,F,Cl,H_to_C,O_to_C,NOSC,GFE,DBE,DBE_O,AI,AI_mod,DBE_AI,Class,control_means,treatment_means,ratio,log2FC,pval,pval.adj,Comment
Feature0342,NA,C8 H16 N2 O9,284.08565,NA,NA,Feature0342,8,16,2,9,0,0,0,0,2,1.125,1,31.799999999999997,2,-7,3,-3,-9,Carbohydrate,798906.35699915,6922139.679117203,8.664519462729181,3.115119739234068,3.3709009437422443e-4,8.733697899695814e-4,Upregulated
Feature0341,3-Deoxytetronic acid,C4 H8 O4,120.04228,NA,NA,3-Deoxytetronic acid,4,8,0,4,0,0,0,0,2,1,0,60.3,1,-3,-Inf,-0.5,-3,Carbohydrate,4254231.975575859,4966102.361500602,1.1673322917066327,0.22321529571421006,0.5135026066693643,0.5776904325030349,Upregulated
Feature0340,6-Deoxy-D-arabino-hexos-2-ulose,C6 H10 O5,162.05281,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Fructose and mannose metabolism;Other,Superpathway of butirocin biosynthesis;Other,6-Deoxy-D-arabino-hexos-2-ulose,6,10,0,5,0,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,704602.158162424,2113680.96582026,2.999821873002292,1.5848768371992195,0.015727759872804406,0.03073653643713775,Upregulated
Feature0339,Oleic acid,C18 H34 O2,282.2559,Biosynthesis of plant secondary metabolites;Other,Other,Oleic acid,18,34,0,2,0,0,0,0,1.8888888888888888,0.1111111111111111,-1.666666666666667,107.8,2,0,0,0.0588235294117647,0,Lipid,115283.96715430982,2891300.979054931,25.07981855954756,4.648455005858741,9.158047565783053e-6,3.319999467812949e-5,Upregulated
Feature0338,DL-TYROSINE,C9 H11 N O3,181.07387,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Central carbon metabolism in cancer;Other,Superpathway of chorismate metabolism;Superpathway of betalain biosynthesis;Other,DL-TYROSINE,9,11,1,3,0,0,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Lignin,710245.4070353217,7720343.943419759,10.869966728325233,3.442275619341485,8.37859011635773e-10,2.604979836176676e-8,Upregulated
Feature0337,Mevalonic acid,C6 H12 O4,148.07361,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant hormones;Biosynthesis of terpenoids and steroids;Other,Superpathway of branched chain amino acid biosynthesis;Methanobacterium thermoautotrophicumÂ biosynthetic metabolism;Superpathway of L-threonine metabolism;Superpathway of coenzyme A biosynthesis II (plants);Superpathway of L-isoleucine biosynthesis I;Other,Mevalonic acid-peak2,6,12,0,4,0,0,0,0,2,0.6666666666666666,-0.666666666666667,79.30000000000001,1,-3,-1.5,-0.25,-3,Amino Sugar,350810.1010018032,1080338.4920498063,3.0795535503815303,1.6227212154214972,0.2397458086164624,0.3333051485643502,Upregulated
Feature0336,MFCD01318772,C8 H13 N3 O2,183.10073,NA,NA,MFCD01318772,8,13,3,2,0,0,0,0,1.625,0.25,0,60.3,4,2,-0.3333333333333333,0,-1,Lipid,3570648.161759712,7347387.80086024,2.0577182259366738,1.0410454400182843,1.0962668191205675e-4,3.0731414109773283e-4,Upregulated
Feature0335,Leu-arg,C12 H25 N5 O3,287.19584,NA,NA,Leu-arg,12,25,5,3,0,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,1284053.1962564404,1253376.2798826643,0.9761093103749812,-0.034885376704315886,0.8811566378119742,0.9022621860230394,Downregulated
Feature0334,Ser-Leu,C9 H18 N2 O4,218.12657,Other,NA,Ser-Leu,9,18,2,4,0,0,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,6606906.071100693,4981780.89141678,0.7540262927616932,-0.4073132639987945,0.11859229776325296,0.17711164120101533,Downregulated
Feature0333,beta-D-Ethyl glucuronide,C8 H14 O7,222.07387,NA,NA,beta-D-Ethyl glucuronide-peak5,8,14,0,7,0,0,0,0,1.75,0.875,0,60.3,2,-5,-5,-0.3333333333333333,-5,Carbohydrate,129513719.21263121,204154.2455347081,0.0015763136660413143,-9.309229643639336,8.500214720950217e-9,1.321397015711352e-7,Downregulated
Feature0332,NA,C8 H11 N O5,201.06375,NA,NA,Feature0332,8,11,1,5,0,0,0,0,1.375,0.625,0.25,53.175,4,-1,-1,0.1111111111111111,-2,Lignin,6150482.508503071,4034277.559110836,0.6559286289382058,-0.6083892499808488,0.07690397103958385,0.12644787545931574,Downregulated
Feature0331,NA,C9 H13 N O4 S,231.05648,NA,NA,Feature0331,9,13,1,4,1,0,0,0,1.4444444444444444,0.4444444444444444,0,60.3,4,0,-0.6666666666666666,0,-2,Lignin,6584512.150637949,1873675.0253874916,0.28455791143250575,-1.8132058042736976,4.7715607259427715e-9,9.065965379291265e-8,Downregulated
Feature0330,"8-Azabicyclo[3.2.1]octane-1,2,3,4-tetrol",C7 H13 N O4,175.08438,NA,NA,"8-Azabicyclo[3.2.1]octane-1,2,3,4-tetrol",7,13,1,4,0,0,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,457038.6321235587,503345.2053507955,1.1013187288174755,0.13923205467817693,0.8456012372513863,0.8763503731514367,Upregulated
Feature0329,NA,C21 H36 N2 O6 S4,540.14577,NA,NA,Feature0329,21,36,2,6,4,0,0,0,1.7142857142857142,0.2857142857142857,-0.4761904761904763,73.87142857142857,5,-1,-0.7777777777777778,-0.3333333333333333,-7,Lipid,16909456.704174217,262076.38717592054,0.015498805890743086,-6.011699122782684,0.05634198358623446,0.09586546460941386,Downregulated
Feature0328,3-methoxyanthranilic acid,C8 H9 N O3,167.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,3-methoxyanthranilic acid,8,9,1,3,0,0,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Lignin,1542870.1361497454,2380728.590231127,1.5430518320694633,0.6257865237450977,0.02473162841256471,0.04647371932470951,Upregulated
Feature0327,cis-trihomoaconitic acid,C9 H12 O6,216.0633,Metabolic pathways;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Other,NA,cis-trihomoaconitic acid-peak2,9,12,0,6,0,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,4,-2,-0.6666666666666666,0.16666666666666666,-2,Tannin,2608731.8013422475,721546.4227089318,0.27658896262838556,-1.8541845084604367,3.632488979520059e-7,2.2184129124926073e-6,Downregulated
Feature0326,asp-leu,C10 H18 N2 O5,246.12159,Metabolic pathways;Other,NA,asp-leu-peak2,10,18,2,5,0,0,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,802316.0467605197,821649.2659603468,1.0240967624639792,0.034352035779006654,0.9725033777521013,0.9782239858565254,Upregulated
Feature0325,"6-(1-Hydroxyethyl)-3-(hydroxymethyl)-2,7-dioxabicyclo[4.1.0]hept-3-en-5-one",C8 H10 O5,186.05284,NA,NA,"6-(1-Hydroxyethyl)-3-(hydroxymethyl)-2,7-dioxabicyclo[4.1.0]hept-3-en-5-one-peak3",8,10,0,5,0,0,0,0,1.25,0.625,0,60.3,4,-1,-0.3333333333333333,0.2727272727272727,-1,Lignin,6985277.655401945,6972614.454007001,0.9981871584753469,-0.0026177509789366196,0.9879285715118407,0.9888030608070424,Downregulated
Feature0324,NA,C13 H11 N7 O4 S,361.05925,NA,NA,Feature0324,13,11,7,4,1,0,0,0,0.8461538461538461,0.3076923076923077,1.5384615384615383,16.453846153846158,12,8,0,0.6666666666666666,0,Lignin,270320.80954925733,157899.54866007628,0.584119102496636,-0.7756655287580121,0.20073133077478125,0.28367816167345117,Downregulated
Feature0323,4-Undecylbenzenesulfonic acid,C17 H28 O3 S,312.17604,NA,NA,4-Undecylbenzenesulfonic acid-peak2,17,28,0,3,1,0,0,0,1.6470588235294117,0.17647058823529413,-1.1764705882352944,93.8294117647059,4,1,0,0.10344827586206896,0,Lipid,506766.6452239235,7275067.257948616,14.355852593127953,3.843567109539118,1.293709997032687e-6,6.412301724422883e-6,Upregulated
Feature0322,Genipin,C11 H14 O5,226.0841,NA,NA,Genipin,11,14,0,5,0,0,0,0,1.2727272727272727,0.4545454545454546,-0.3636363636363633,70.66363636363636,5,0,0,0.29411764705882354,0,Lignin,283477.0286265265,351663.8332344012,1.24053731950785,0.3109651369708048,0.3388301259244094,0.41985472125415946,Upregulated
Feature0321,Ro 20-1724,C15 H22 N2 O3,278.16312,NA,NA,Ro 20-1724,15,22,2,3,0,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Lignin,5014541.450965178,1380566.932879229,0.27531269735810104,-1.860856946656984,4.453540619410566e-6,1.7391680371099693e-5,Downregulated
Feature0320,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.074,NA,NA,Phenyl D-glucopyranosiduronic acid,12,14,0,7,0,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,3903019.7203978715,4263100.656413693,1.0922570117014718,0.12731236713664887,0.386185419764279,0.46505427309642045,Upregulated
Feature0319,NA,C6 H12 O8 S,244.02539,NA,NA,Feature0319,6,12,0,8,1,0,0,0,2,1.3333333333333333,1,31.799999999999997,1,-7,2.6666666666666665,-4,-8,Carbohydrate,9924559.478169026,3745503.074090699,0.37739741318792563,-1.4058435606446624,5.383655912974543e-4,0.0013638594979535508,Downregulated
Feature0318,NA,C7 H16 O6,196.09468,NA,NA,Feature0318,7,16,0,6,0,0,0,0,2.2857142857142856,0.8571428571428571,-0.5714285714285712,76.58571428571427,0,-6,-6,-0.75,-6,Carbohydrate,381780.43738795206,361695.4321402944,0.9473912142144466,-0.077967801971667,0.8048975252501767,0.846999857340186,Downregulated
Feature0317,"2,2-Bis(hydroxymethyl)propionic acid",C5 H10 O4,134.05797,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis,"2,2-Bis(hydroxymethyl)propionic acid",5,10,0,4,0,0,0,0,2,0.8,-0.4000000000000003,71.7,1,-3,-3,-0.3333333333333333,-3,Carbohydrate,2026604.0020887367,9234141.961480215,4.556460932655303,2.1879136977966445,2.993978375411205e-8,3.303034207711717e-7,Upregulated
Feature0316,Adipic acid,C6 H10 O4,146.05797,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of coenzyme A biosynthesis II (plants);Superpathway of L-isoleucine biosynthesis I;Other,Adipic acid,6,10,0,4,0,0,0,0,1.6666666666666667,0.6666666666666666,-0.33333333333333304,69.79999999999998,2,-2,-1,0,-2,Amino Sugar,464018.33790152945,371273.5579315358,0.8001269079376875,-0.32169925122274196,0.05342615890465229,0.09135873172695541,Downregulated
Feature0315,D-(+)-Mannose,C6 H12 O6,180.06334,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;ABC transporters;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Galactose metabolism;Carbon metabolism;Biosynthesis of phenylpropanoids;Biosynthesis of plant hormones;Ascorbate and aldarate metabolism;Biosynthesis of terpenoids and steroids;Fructose and mannose metabolism;Glucagon signaling pathway;Central carbon metabolism in cancer;Phosphotransferase system (PTS);Other,Superpathway of anaerobic sucrose degradation;Chitin biosynthesis;Superpathway of scopolin and esculin biosynthesis;Homolactic fermentation;Superpathway of CMP-sialic acids biosynthesis;Superpathway of betalain biosynthesis;Other,D-(+)-Mannose,6,12,0,6,0,0,0,0,2,1,0,60.3,1,-5,-Inf,-0.6666666666666666,-5,Carbohydrate,12397832.770177837,425942.6111831415,0.034356215241725,-4.8632850750893875,1.002768319132374e-6,5.118608434974208e-6,Downregulated
Feature0314,N-(2-Hydroxyethyl)glutamine,C7 H14 N2 O4,190.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Other,Other,N-(2-Hydroxyethyl)glutamine,7,14,2,4,0,0,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,2459242.007121964,4561462.418832423,1.8548245376512071,0.8912827175019973,5.562895642875872e-5,1.640095094709955e-4,Upregulated
Feature0313,Glycyl-L-leucine,C8 H16 N2 O3,188.11609,Metabolic pathways;Other,Superpathway of L-lysine degradation,Glycyl-L-leucine,8,16,2,3,0,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,3166300.4590552417,5365099.03903,1.6944377542208466,0.7608066398751212,0.009843442313374582,0.020158426773497648,Upregulated
Feature0312,NA,C12 H9 N5 O7 S,367.02222,NA,NA,Feature0312,12,9,5,7,1,0,0,0,0.75,0.5833333333333334,1.8333333333333337,8.04999999999999,11,4,2,0.6,-2,Condensed HC,2198641.8581087887,11346029.802692374,5.160472025422056,2.3675030341736845,1.389044806139748e-12,2.375266618498969e-10,Upregulated
Feature0311,NA,C28 H43 O4 P,474.28996,NA,NA,Feature0311,28,43,0,4,0,1,0,0,1.5357142857142858,0.14285714285714285,-1.4285714285714288,101.01428571428572,8,4,0.13043478260869565,0.2,3,Lipid,2211201.715272377,15558058.358309673,7.036019486984355,2.814759478508674,2.503832710844439e-7,1.6156807303939587e-6,Upregulated
Feature0310,NA,C8 H11 O4 P S,234.01153,NA,NA,Feature0310,8,11,0,4,1,1,0,0,1.375,0.5,-0.75,81.675,4,0,-1,0,-2,Lignin,2572030.568759425,687883.3351431834,0.2674475737179796,-1.9026719792605662,0.32580787384311183,0.4157697494565084,Downregulated
Feature0309,(E)-Ferulic acid,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of phenylpropanoids;Other,Superpathway of scopolin and esculin biosynthesis;Other,(E)-Ferulic acid,10,10,0,4,0,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Lignin,395698.0111767797,12435288.26868784,31.426208667832615,4.973896327378976,0.0013393364899930184,0.0032031683886546316,Upregulated
Feature0308,3-Hydroxybutyric acid,C4 H8 O3,104.04735,Metabolic pathways;Microbial metabolism in diverse environments;Carbon metabolism;Other,NA,3-Hydroxybutyric acid-peak3,4,8,0,3,0,0,0,0,2,0.75,-0.5,74.55,1,-2,-2,-0.2,-2,Carbohydrate,764326.8370705002,1579124.538829932,2.066033092442986,1.0468633625868213,0.3253111829277352,0.4157697494565084,Upregulated
Feature0307,"2,4-Dihydroxybenzoic acid",C7 H6 O4,154.02667,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of phenylpropanoids;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Superpathway of chorismate metabolism;Other,"2,4-Dihydroxybenzoic acid",7,6,0,4,0,0,0,0,0.8571428571428571,0.5714285714285714,0.2857142857142856,52.15714285714286,5,1,0.3333333333333333,0.6,1,Lignin,11068028.230703542,12191413.494639458,1.1014982289997743,0.13946717546067808,0.16316502754243017,0.23645101448945388,Upregulated
Feature0306,NA,C12 H17 N O4,239.11571,NA,NA,Feature0306,12,17,1,4,0,0,0,0,1.4166666666666667,0.3333333333333333,-0.5,74.55,5,1,0,0.2222222222222222,0,Lignin,7749667.032912102,12181573.516717812,1.571883471249,0.6524942699613394,0.00610006259858147,0.012798904347943943,Upregulated
Feature0305,6-Deoxy-3-O-methyl-beta-D-galactopyranose,C7 H14 O5,178.08407,NA,NA,6-Deoxy-3-O-methyl-beta-D-galactopyranose-peak2,7,14,0,5,0,0,0,0,2,0.7142857142857143,-0.5714285714285712,76.58571428571427,1,-4,-2,-0.3333333333333333,-4,Carbohydrate,545431.9312996583,322099.4777701189,0.5905401926187535,-0.7598928409915414,1.8217635623208497e-4,4.90585148278528e-4,Downregulated
Feature0304,NA,C6 H7 N3 O5 P2,262.98597,NA,NA,Feature0304,6,7,3,5,0,2,0,0,1.1666666666666667,0.8333333333333334,0.3333333333333335,50.8,6,1,1,1,-4,Tannin,21881153.48683566,464822.5981583335,0.02124305733872688,-5.556864773444395,5.5037105696674305e-9,9.906679025401375e-8,Downregulated
Feature0303,diphthinate,C13 H22 N4 O4,298.16421,NA,NA,diphthinate,13,22,4,4,0,0,0,0,1.6923076923076923,0.3076923076923077,-0.1538461538461542,64.6846153846154,5,1,-0.6,-0.14285714285714285,-3,Protein,1491549.5436199703,1417817.8991942033,0.9505670832449713,-0.07313965081230103,0.953961152871459,0.9652506339705296,Downregulated
Feature0302,NA,C3 H9 N4 O2 P,164.04635,NA,NA,Feature0302,3,9,4,2,0,1,0,0,3,0.6666666666666666,0.6666666666666665,41.3,2,0,1.25,1.3333333333333333,-5,Other,221408.9493204012,1637436.7177782722,7.395530861802407,2.886653709758608,0.020834662921609338,0.039807009604415605,Upregulated
Feature0301,"6-(1-Hydroxyethyl)-3-(hydroxymethyl)-2,7-dioxabicyclo[4.1.0]hept-3-en-5-one",C8 H10 O5,186.05281,NA,NA,"6-(1-Hydroxyethyl)-3-(hydroxymethyl)-2,7-dioxabicyclo[4.1.0]hept-3-en-5-one-peak2",8,10,0,5,0,0,0,0,1.25,0.625,0,60.3,4,-1,-0.3333333333333333,0.2727272727272727,-1,Lignin,9957244.174919853,2767992.9671983994,0.2779878567375475,-1.846906231388774,0.01116560742926347,0.022462574945930038,Downregulated
Feature0300,DL-Nordihydroguaiaretic acid,C18 H22 O4,302.1519,NA,NA,DL-Nordihydroguaiaretic acid,18,22,0,4,0,0,0,0,1.2222222222222223,0.2222222222222222,-0.7777777777777777,82.46666666666667,8,4,0.2857142857142857,0.375,4,Lignin,63755.27873352452,10203121.314919908,160.03571025962415,7.322250052800375,0.020327598121787926,0.039056396391300395,Upregulated
Feature0299,N-Acetyl-Î±-D-glucosamine 1-phosphate,C8 H16 N O9 P,301.05637,Metabolic pathways;Galactose metabolism;Phosphotransferase system (PTS);Other,Chitin biosynthesis;Superpathway of CMP-sialic acids biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Other,N-Acetyl-Î±-D-glucosamine 1-phosphate,8,16,1,9,0,1,0,0,2,1.125,0,60.3,2,-7,3,-3,-9,Carbohydrate,873245.821922512,5521599.237078667,6.323075471374691,2.660626439427802,2.4281921872426913e-5,7.618731449880738e-5,Upregulated
Feature0298,3-O-methylgallic acid,C8 H8 O5,184.03711,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,3-O-methylgallic acid,8,8,0,5,0,0,0,0,1,0.625,0.25,53.175,5,0,0,0.4545454545454546,0,Lignin,372622.9319120885,864453.026197149,2.3199136504059714,1.2140711077453106,0.0964551875449956,0.15131960614857107,Upregulated
Feature0297,Wikstromol,C20 H22 O7,374.13667,NA,NA,Wikstromol,20,22,0,7,0,0,0,0,1.1,0.35,-0.4000000000000003,71.7,10,3,0.2307692307692308,0.3939393939393939,3,Lignin,156093.9504675253,158084.30938532896,1.0127510317462158,0.018279554779364004,0.926054038877858,0.9397937130451852,Upregulated
Feature0296,Propyl gallate,C10 H12 O5,212.06837,NA,NA,Propyl gallate,10,12,0,5,0,0,0,0,1.2,0.5,-0.20000000000000015,66,5,0,0,0.3333333333333333,0,Lignin,657752.721073678,381784.7151897335,0.5804380627518042,-0.7847859663463367,0.018750319726764837,0.03622943133646087,Downregulated
Feature0295,D-Sedoheptulose 7-phosphate,C7 H15 O10 P,290.04036,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Carbon metabolism;Biosynthesis of amino acids;Other,Other,D-Sedoheptulose 7-phosphate,7,15,0,10,0,1,0,0,2.142857142857143,1.4285714285714286,0,60.3,1,-9,2.5,-5,-10,Carbohydrate,1000710.7073594714,2983586.4142648573,2.981467463396597,1.5760225927900875,0.0039234017259527874,0.008439015033181467,Upregulated
Feature0294,Acetyl-L-methionine,C7 H13 N O3 S,191.06167,NA,NA,Acetyl-L-methionine,7,13,1,3,1,0,0,0,1.8571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,332299.8766504108,913004.344298676,2.7475313969471715,1.458135967420612,0.13024592097306523,0.19283162325882386,Upregulated
Feature0293,Dodecyl sulfate,C12 H26 O4 S,266.15528,NA,NA,Dodecyl sulfate-peak2,12,26,0,4,1,0,0,0,2.1666666666666665,0.3333333333333333,-1.333333333333333,98.29999999999998,0,-4,-0.7142857142857143,-0.3333333333333333,-5,Protein,582768.3562988346,8516012.294311184,14.613031408219264,3.8691835847298384,1.372796874490436e-7,9.781177730744358e-7,Upregulated
Feature0292,Glycolic acid,C2 H4 O3,76.01607,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Carbon metabolism;Other,Other,Glycolic acid-peak2,2,4,0,3,0,0,0,0,2,1.5,1,31.799999999999997,1,-2,2,-1,-2,Carbohydrate,20767024.524767436,4911146.9717518175,0.236487753259723,-2.0801626207051096,2.610732027198721e-5,8.117003211836023e-5,Downregulated
Feature0291,NA,C12 H22 N6 O7 P2 S2,488.04681,NA,NA,Feature0291,12,22,6,7,2,2,0,0,1.8333333333333333,0.5833333333333334,0.3333333333333335,50.8,6,-1,2.2,5,-11,Amino Sugar,2149557.6620468935,3586788.1739330958,1.6686168681409619,0.7386527348767237,0.17602800873925323,0.25083991245343584,Upregulated
Feature0290,(2E)-3-[4-(Sulfooxy)phenyl]acrylic acid,C9 H8 O6 S,244.00407,NA,NA,(2E)-3-[4-(Sulfooxy)phenyl]acrylic acid-peak3,9,8,0,6,1,0,0,0,0.8888888888888888,0.6666666666666666,0.6666666666666665,41.3,6,0,-0.5,0.4,-1,Tannin,324256.0581212494,378450.57101155876,1.1671349278848147,0.2229713549937951,0.3986143104420312,0.47500381244311735,Upregulated
Feature0289,NA,C23 H51 N6 O15 P S3,778.23108,NA,NA,Feature0289,23,51,6,15,3,1,0,0,2.217391304347826,0.6521739130434783,-0.08695652173913082,62.77826086956522,2,-13,11.5,-2.8181818181818183,-23,Other,233681.11852595228,285432.78864637704,1.2214627799065303,0.2886099028500436,0.0913568335759384,0.1453211027114927,Upregulated
Feature0288,"N'-(2-Thienylcarbonyl)-2,5-bis(2,2,2-trifluoroethoxy)benzohydrazide",C16 H12 F6 N2 O4 S,442.04207,NA,NA,"N'-(2-Thienylcarbonyl)-2,5-bis(2,2,2-trifluoroethoxy)benzohydrazide",16,12,2,4,1,0,6,0,0.75,0.25,0.25,53.175,12,8,0.5555555555555556,0.6363636363636364,5,Condensed HC,7717707.063005382,399590.80145425396,0.05177584458597574,-4.271577007382812,0.012583263007607561,0.025020209003498755,Downregulated
Feature0287,"(1S,2S,3R,4S,5R,6S)-2,3,4,6-Tetrahydroxy-5-methoxycyclohexyl 6-O-alpha-D-galactopyranosyl-alpha-D-galactopyranoside",C19 H34 O16,518.18462,NA,NA,"(1S,2S,3R,4S,5R,6S)-2,3,4,6-Tetrahydroxy-5-methoxycyclohexyl 6-O-alpha-D-galactopyranosyl-alpha-D-galactopyranoside",19,34,0,16,0,0,0,0,1.7894736842105263,0.8421052631578947,-0.10526315789473716,63.3,3,-13,-4.333333333333333,-0.4545454545454546,-13,Carbohydrate,1241494.8265155607,277714.60367770714,0.22369372610045773,-2.1604033009431065,7.233775250147997e-5,2.0965687589411992e-4,Downregulated
Feature0286,(-)-Shikimic acid,C7 H10 O5,174.05278,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Degradation of aromatic compounds;Biosynthesis of amino acids;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant hormones;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Superpathway of chorismate metabolism;Other,(-)-Shikimic acid-peak2,7,10,0,5,0,0,0,0,1.4285714285714286,0.7142857142857143,0,60.3,3,-2,-1,0.1111111111111111,-2,Tannin,737425.6886028363,1866197.34102433,2.5306920681867227,1.339531972590091,7.13107375394056e-6,2.6508991563561647e-5,Upregulated
Feature0285,"2,3-Dihydroxypropyl beta-D-galactopyranoside",C9 H18 O8,254.10022,Galactose metabolism;Other,NA,"2,3-Dihydroxypropyl beta-D-galactopyranoside",9,18,0,8,0,0,0,0,2,0.8888888888888888,-0.22222222222222232,66.63333333333333,1,-7,-7,-0.6,-7,Carbohydrate,7891808.395257345,5509421.908891343,0.6981190663729596,-0.5184549813514778,0.11141051168320987,0.17086275782806176,Downregulated
Feature0284,NA,C31 H27 N2 O10 P,618.14042,NA,NA,Feature0284,31,27,2,10,0,1,0,0,0.8709677419354839,0.3225806451612903,-0.193548387096774,65.81612903225806,20,10,0.3888888888888889,0.5217391304347826,7,Lignin,78851.70881674446,76371.14681693749,0.9685414300205981,-0.04611433247403992,0.8219197051372862,0.8560291268696524,Downregulated
Feature0283,NA,C2 H5 N O4 S4,234.91002,NA,NA,Feature0283,2,5,1,4,4,0,0,0,2.5,2,7,-139.2,1,-3,1.1428571428571428,1.2,-8,Other,390751.6530337287,334108.43455795804,0.855040361221757,-0.22593557247931154,0.2538152565588494,0.347219270972506,Downregulated
Feature0282,D-Glucono-delta-lactone,C6 H10 O6,178.04779,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Galactose metabolism;Carbon metabolism;Ascorbate and aldarate metabolism;Other,Superpathway of microbial D-galacturonate and D-glucuronate degradation;Other,D-Glucono-delta-lactone-peak2,6,10,0,6,0,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,1015610.5652284116,2776008.3058668156,2.7333393339035315,1.450664576198601,0.026042223037014752,0.04804250232958342,Upregulated
Feature0281,NA,C12 H10 N2 O7 S,326.02086,NA,NA,Feature0281,12,10,2,7,1,0,0,0,0.8333333333333334,0.5833333333333334,1,31.799999999999997,9,2,-0.5,0.4545454545454546,-1,Lignin,772082.6022906553,3604396.0964446035,4.668407351429616,2.2229304518436503,0.012050845940166808,0.024101691880333617,Upregulated
Feature0280,NA,C17 H33 N O8 S2,443.16496,NA,NA,Feature0280,17,33,1,8,2,0,0,0,1.9411764705882353,0.4705882352941176,-0.5882352941176467,77.06470588235292,2,-6,-1.5,-0.5,-9,Protein,15233925.774290126,650267.554579489,0.04268548791782402,-4.550110519637396,2.596651086124009e-9,5.4470897539881624e-8,Downregulated
Feature0279,NA,C16 H28 O14,444.14812,NA,NA,Feature0279,16,28,0,14,0,0,0,0,1.75,0.875,0,60.3,3,-11,-5.5,-0.4444444444444444,-11,Carbohydrate,1612857.6114478004,233944.95889287707,0.1450499766578115,-2.7853780315173418,0.029355519900154788,0.05311951220028009,Downregulated
Feature0278,Phloroacetophenone,C8 H8 O4,168.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Phloroacetophenone,8,8,0,4,0,0,0,0,1,0.5,0,60.3,5,1,0.25,0.5,1,Lignin,2990769.8673999943,4762576.615342832,1.5924249696561061,0.6712253985694093,0.13112584993908183,0.19329758913433612,Upregulated
Feature0277,Dodecyl sulfate,C12 H26 O4 S,266.15522,NA,NA,Dodecyl sulfate-peak1,12,26,0,4,1,0,0,0,2.1666666666666665,0.3333333333333333,-1.333333333333333,98.29999999999998,0,-4,-0.7142857142857143,-0.3333333333333333,-5,Protein,7539872.435399502,3837544.550393694,0.5089667740765115,-0.9743566162673998,9.642844520163682e-4,0.002355609161354271,Downregulated
Feature0276,2-(Benzoyloxy)-3-hydroxysuccinic acid,C11 H10 O7,254.04268,NA,NA,2-(Benzoyloxy)-3-hydroxysuccinic acid,11,10,0,7,0,0,0,0,0.9090909090909092,0.6363636363636364,0.36363636363636376,49.93636363636363,7,0,0,0.4666666666666667,0,Lignin,601012.2281928384,861054.7493934041,1.4326742601934708,0.5187106287042172,0.040698802140382226,0.07174737284541609,Upregulated
Feature0275,trans-Aconitic acid,C6 H6 O6,174.01637,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant hormones;Ascorbate and aldarate metabolism;Biosynthesis of terpenoids and steroids;Other,Superpathway of betalain biosynthesis;Other,trans-Aconitic acid,6,6,0,6,0,0,0,0,1,1,1,31.799999999999997,4,-2,-Inf,0.3333333333333333,-2,Tannin,354246.2788362297,1090564.0993763155,3.0785477915506636,1.622249965206551,0.24521610261846535,0.3381609157077224,Upregulated
Feature0274,NA,C50 H80 O5 P2 S,854.52014,NA,NA,Feature0274,50,80,0,5,1,2,0,0,1.6,0.1,-1.5599999999999996,104.76,12,7,0.09523809523809525,0.14606741573033707,4,Lipid,65526.09688079127,370292.66481115384,5.651071594952632,2.4985244671976705,0.04575606036531912,0.08024909048686739,Upregulated
Feature0273,leu-gln,C11 H21 N3 O4,259.15323,NA,NA,leu-gln-peak2,11,21,3,4,0,0,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,2378885.1176147107,852082.4935669447,0.3581856421975186,-1.481220586557317,0.006326293636983969,0.013192636730783644,Downregulated
Feature0272,"N-acetyl-LL-2,6-diaminopimelic acid",C9 H16 N2 O5,232.10586,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,Other,"N-acetyl-LL-2,6-diaminopimelic acid",9,16,2,5,0,0,0,0,1.7777777777777777,0.5555555555555556,0,60.3,3,-2,-2,-0.3333333333333333,-4,Amino Sugar,4522895.550300924,2160919.177816192,0.4777733984311043,-1.0656015655383113,6.009381158911789e-5,1.7565883387588303e-4,Downregulated
Feature0271,NA,C11 H9 N S,187.04563,NA,NA,Feature0271,11,9,1,0,1,0,0,0,0.8181818181818182,0,-0.3636363636363633,70.66363636363636,8,8,0.6666666666666666,0.6666666666666666,6,Unsaturated HC,4305383.531568223,6406289.0398895815,1.487971743496708,0.5733471300049245,0.0015792215662742838,0.003750651219901424,Upregulated
Feature0270,leu-gln,C11 H21 N3 O4,259.15324,NA,NA,leu-gln-peak1,11,21,3,4,0,0,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,1836536.0051292744,2435703.7932245145,1.326248865484706,0.40735151701352657,0.10152202566421784,0.1578206035325568,Upregulated
Feature0269,Gly-Phe,C11 H14 N2 O3,222.10048,NA,NA,Gly-Phe,11,14,2,3,0,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818168,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Lignin,2648651.0366847254,1725343.943014319,0.6514047789299963,-0.6183737910066072,0.0067181445650181795,0.013919170384948013,Downregulated
Feature0268,3-formylsalicylic acid,C8 H6 O4,166.02653,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;ABC transporters;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate,3-formylsalicylic acid,8,6,0,4,0,0,0,0,0.75,0.5,0.25,53.175,6,2,0.5,0.6666666666666666,2,Condensed HC,2243227.1465111407,2016914.9887981226,0.8991131334760288,-0.15342543650496385,0.6857827490638182,0.7332166085631922,Downregulated
Feature0267,NA,C9 H22 N O8 P,303.10844,NA,NA,Feature0267,9,22,1,8,0,1,0,0,2.4444444444444446,0.8888888888888888,-0.8888888888888893,85.63333333333334,0,-8,10,-2,-10,Carbohydrate,30767895.32210416,43605232.37296002,1.4172315628502972,0.5030755008684266,0.03362875433858741,0.059901218665608824,Upregulated
Feature0266,Gly-thr,C6 H12 N2 O4,176.0797,Other,NA,Gly-thr,6,12,2,4,0,0,0,0,2,0.6666666666666666,0.3333333333333335,50.8,2,-2,-Inf,-1,-4,Amino Sugar,1920027.829985683,1961033.618305715,1.0213568718534345,0.03048704574037852,0.901644158327777,0.9186496514888252,Upregulated
Feature0265,NA,C9 H24 N6 O P2,294.14866,NA,NA,Feature0265,9,24,6,1,0,2,0,0,2.6666666666666665,0.1111111111111111,-1.5555555555555554,104.63333333333333,2,1,-Inf,-13,-7,Other,191378.28996619815,2043776.5532705185,10.679249739515893,3.416738390311678,0.001860834756554823,0.004358941690011982,Upregulated
Feature0264,NA,C7 H17 N O10,275.08534,NA,NA,Feature0264,7,17,1,10,0,0,0,0,2.4285714285714284,1.4285714285714286,0.8571428571428572,35.87142857142857,0,-10,2.75,-6,-11,Carbohydrate,140273.44040475498,1549563.2099708347,11.046732763519698,3.465547828950991,0.0021138363934857323,0.0048518929300142314,Upregulated
Feature0263,D-Glucosamine 6-phosphate,C6 H14 N O8 P,259.04576,Metabolic pathways;Biosynthesis of secondary metabolites;Galactose metabolism;Phosphotransferase system (PTS);Other,Chitin biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Other,D-Glucosamine 6-phosphate,6,14,1,8,0,1,0,0,2.3333333333333335,1.3333333333333333,0,60.3,1,-7,2.25,-Inf,-9,Carbohydrate,654347.5988259165,1399100.8476956321,2.138161506523463,1.0963708314775893,0.0132907658830517,0.02627423082083053,Upregulated
Feature0262,Luteolin,C15 H10 O6,286.04782,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of phenylpropanoids;Other,Other,Luteolin,15,10,0,6,0,0,0,0,0.6666666666666666,0.4,0.1333333333333333,56.5,11,5,0.5555555555555556,0.6666666666666666,5,Condensed HC,131085.46614287153,309554.80591397686,2.3614731291155464,1.2396871193494547,0.34951547697864005,0.4270386425552202,Upregulated
Feature0261,NA,C7 H7 N3 O4 P2,258.99119,NA,NA,Feature0261,7,7,3,4,0,2,0,0,1,0.5714285714285714,0,60.3,7,3,1,NA,-2,Lignin,351900.28854630596,403096.9322314739,1.1454862225224662,0.19596010655350188,0.6460691808848107,0.6992267717171052,Upregulated
Feature0260,Abietin,C16 H22 O8,342.13151,Biosynthesis of secondary metabolites;Other,NA,Abietin,16,22,0,8,0,0,0,0,1.375,0.5,-0.375,70.9875,6,-2,-0.25,0.16666666666666666,-2,Lignin,415274.6132556767,158427.21541886975,0.38149988070984997,-1.3902454889398366,0.29497547283550934,0.3895042923156147,Downregulated
Feature0259,2-Aminomuconic acid,C6 H7 N O4,157.03757,Metabolic pathways;Other,Other,2-Aminomuconic acid,6,7,1,4,0,0,0,0,1.1666666666666667,0.6666666666666666,0.6666666666666665,41.3,4,0,-1,0.3333333333333333,-1,Tannin,5560001.358577008,2090136.5767335135,0.3759237528798824,-1.411488019412346,1.5001744698548757e-5,4.9322664002252263e-5,Downregulated
Feature0258,3653579,C18 H24 O5,320.16251,NA,NA,3653579,18,24,0,5,0,0,0,0,1.3333333333333333,0.2777777777777778,-0.7777777777777777,82.46666666666667,7,2,0.15384615384615383,0.2903225806451613,2,Lignin,145748.4997271236,15045635.604240682,103.23012334541863,6.68972021150127,0.02612837845994888,0.04804250232958342,Upregulated
Feature0257,"2-Hydroxy-3,4,5-trimethoxybenzoic acid",C10 H12 O6,228.06339,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,"2-Hydroxy-3,4,5-trimethoxybenzoic acid",10,12,0,6,0,0,0,0,1.2,0.6,0,60.3,5,-1,-0.25,0.2857142857142857,-1,Lignin,1406089.1971158686,960313.9398507539,0.6829680092987865,-0.5501100916383125,0.2939670025416289,0.3895042923156147,Downregulated
Feature0256,NA,C14 H22 O10,350.12144,NA,NA,Feature0256,14,22,0,10,0,0,0,0,1.5714285714285714,0.7142857142857143,-0.14285714285714324,64.37142857142858,4,-6,-1.5,-0.1111111111111111,-6,Carbohydrate,243288.4110543425,484053.616424887,1.9896287469145646,0.9924992574259376,0.10832514024741866,0.1668792701108882,Upregulated
Feature0255,Troxipide,C15 H22 N2 O4,294.1581,NA,NA,Troxipide,15,22,2,4,0,0,0,0,1.4666666666666666,0.26666666666666666,-0.5333333333333332,75.5,6,2,0,0.18181818181818185,0,Lignin,2297011.8688845034,2207923.575193373,0.9612155710216708,-0.057068075577102306,0.7842366255479951,0.8278053269673282,Downregulated
Feature0254,4-hydroxy-4-(indol-3-ylmethyl)glutamic acid,C14 H16 N2 O5,292.10606,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,4-hydroxy-4-(indol-3-ylmethyl)glutamic acid,14,16,2,5,0,0,0,0,1.1428571428571428,0.35714285714285715,0,60.3,8,3,0.14285714285714285,0.3684210526315789,1,Lignin,3689221.270129294,174930.48619987394,0.04741664253544305,-4.398462677291189,3.142659537343088e-7,1.954162839584247e-6,Downregulated
Feature0253,NA,C11 H20 N4 O3,256.15361,NA,NA,Feature0253,11,20,4,3,0,0,0,0,1.818181818181818,0.2727272727272727,-0.18181818181818168,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,437492.3332546913,672977.3267445229,1.5382608461683402,0.6213001649153954,0.5416736313937407,0.6014687725216212,Upregulated
Feature0252,MFCD00037215,C8 H14 N2 O5,218.09029,NA,NA,MFCD00037215,8,14,2,5,0,0,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,4435692.711087191,1856054.541770846,0.4184362314214336,-1.2569203182811082,6.85699705013247e-6,2.5770252649948403e-5,Downregulated
Feature0251,N-Acetyl-4-aminosalicylic acid,C9 H9 N O4,195.05319,Metabolic pathways;Microbial metabolism in diverse environments;Other,Superpathway of betalain biosynthesis,N-Acetyl-4-aminosalicylic acid,9,9,1,4,0,0,0,0,1,0.4444444444444444,0.22222222222222232,53.96666666666666,6,2,0.25,0.5,1,Lignin,563590.6031469252,3466683.404055389,6.1510667223662745,2.6208366253489137,7.256671830086463e-7,4.00287381595092e-6,Upregulated
Feature0250,NA,C12 H19 N O8,305.11118,NA,NA,Feature0250,12,19,1,8,0,0,0,0,1.5833333333333333,0.6666666666666666,0,60.3,4,-4,-1.6666666666666667,-0.14285714285714285,-5,Amino Sugar,137775.31944314326,2514240.8878722535,18.248848182927446,4.189733502813217,1.142304333797009e-9,3.255567351321476e-8,Upregulated
Feature0249,"10,16-Dihydroxyhexadecanoic acid",C16 H32 O4,288.23015,Other,NA,"10,16-Dihydroxyhexadecanoic acid",16,32,0,4,0,0,0,0,2,0.25,-1.5,103.05,1,-3,-0.25,-0.07142857142857142,-3,Lipid,5831432.86725911,89734.03610259834,0.015387990935540878,-6.02205130486211,7.197466126790838e-8,6.52313195313185e-7,Downregulated
Feature0248,"1-(3-Methoxyphenyl)-2,3-butanedione",C11 H12 O3,192.07867,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,"1-(3-Methoxyphenyl)-2,3-butanedione",11,12,0,3,0,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,355316.51606720267,282080.96695226553,0.7938864482700102,-0.33299542534410204,0.6380148118429034,0.6927017957151522,Downregulated
Feature0247,NA,C28 H41 N O6,487.29353,NA,NA,Feature0247,28,41,1,6,0,0,0,0,1.4642857142857142,0.21428571428571427,-0.9285714285714288,86.76428571428572,9,3,0.09523809523809525,0.20833333333333337,2,Lignin,77863.75957744033,81357.4758662562,1.044869606961903,0.06332291443356121,0.7239816021483854,0.7689494035240614,Upregulated
Feature0246,"9-Hydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-7H-furo[3,2-g]chromen-7-one",C14 H14 O5,262.08415,NA,NA,"9-Hydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-7H-furo[3,2-g]chromen-7-one",14,14,0,5,0,0,0,0,1,0.35714285714285715,-0.2857142857142856,68.44285714285714,8,3,0.3333333333333333,0.4782608695652174,3,Lignin,601839.2422601928,63163.34486062966,0.1049505256975621,-3.2522187017745283,0.2731139580976857,0.37065465741828774,Downregulated
Feature0245,(2E)-3-[4-(Sulfooxy)phenyl]acrylic acid,C9 H8 O6 S,244.00421,NA,NA,(2E)-3-[4-(Sulfooxy)phenyl]acrylic acid-peak2,9,8,0,6,1,0,0,0,0.8888888888888888,0.6666666666666666,0.6666666666666665,41.3,6,0,-0.5,0.4,-1,Tannin,79908.60763127214,101897.54368483536,1.2751760630723075,0.3506964531902397,0.05671070952867497,0.09601516167726158,Upregulated
Feature0244,"(1R,5R)-3,3,5-Trimethylcyclohexyl 5-oxo-L-prolinate",C14 H23 N O3,253.16783,NA,NA,"(1R,5R)-3,3,5-Trimethylcyclohexyl 5-oxo-L-prolinate",14,23,1,3,0,0,0,0,1.6428571428571428,0.21428571428571427,-1,88.8,4,1,0,0.13043478260869565,0,Lipid,66848.08110570391,86338.57155755839,1.2915639481264245,0.3691190761782447,0.08462247114902179,0.13716059304722963,Upregulated
Feature0243,NA,C7 H17 N8 O6 P,340.10075,Other,NA,Feature0243,7,17,8,6,0,1,0,0,2.4285714285714284,0.8571428571428571,2,3.299999999999997,4,-2,1.375,1.6,-11,Carbohydrate,3857967.9916928695,670314.8897760321,0.1737481729292158,-2.524930287812764,8.89880208507161e-9,1.3232131796063004e-7,Downregulated
Feature0242,NA,C4 H10 N6 P2,204.04415,NA,NA,Feature0242,4,10,6,0,0,2,0,0,2.5,0,-0.5,74.55,4,4,1,1,-4,Lipid,5685450.074508821,3123928.073869518,0.5494601188876681,-0.8639133241241307,3.8232913717352776e-6,1.551968140729691e-5,Downregulated
Feature0241,"(2E)-3-(4,5-Dihydroxy-2,3-dimethoxyphenyl)-2-propen-1-yl hydrogen sulfate",C11 H14 O8 S,306.04103,NA,NA,"(2E)-3-(4,5-Dihydroxy-2,3-dimethoxyphenyl)-2-propen-1-yl hydrogen sulfate",11,14,0,8,1,0,0,0,1.2727272727272727,0.7272727272727273,0.36363636363636376,49.93636363636363,5,-3,-2,0,-4,Tannin,70378.05172583206,80618.17127164027,1.1455016058941228,0.195979481177606,0.251489696115908,0.34541958261703026,Upregulated
Feature0240,L-Alanyl-L-glutamine,C8 H15 N3 O4,217.10623,Metabolic pathways;Biosynthesis of amino acids;Other,NA,L-Alanyl-L-glutamine,8,15,3,4,0,0,0,0,1.875,0.5,0.25,53.175,3,-1,-4,-0.6666666666666666,-4,Protein,2645364.6846314655,591154.5448425596,0.2234680716337284,-2.1618593761686253,4.70314948440473e-7,2.773236420114513e-6,Downregulated
Feature0239,Catechin,C15 H14 O6,290.07918,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of phenylpropanoids;Other,NA,Catechin,15,14,0,6,0,0,0,0,0.9333333333333332,0.4,-0.13333333333333375,64.10000000000001,9,3,0.3333333333333333,0.5,3,Lignin,767630.2255060578,1942617.1445162445,2.5306678658146637,1.3395181752539589,1.5142923158586221e-5,4.9322664002252263e-5,Upregulated
Feature0238,NA,C30 H50 O6 S,538.3329,NA,NA,Feature0238,30,50,0,6,1,0,0,0,1.6666666666666667,0.2,-1.2000000000000002,94.5,6,0,-0.04347826086956521,0.07692307692307693,-1,Lipid,62600.51499506247,1540485.0818363205,24.608185443168065,4.621066375249141,0.00291398469522622,0.006429566230757208,Upregulated
Feature0237,MFCD00155202,C10 H12 O4,196.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,MFCD00155202-peak2,10,12,0,4,0,0,0,0,1.2,0.4,-0.4000000000000003,71.7,5,1,0.16666666666666666,0.375,1,Lignin,370515.705329322,3044506.965835411,8.216944442690737,3.038602012288906,0.004546146465186044,0.00971738806933517,Upregulated
Feature0236,pseudouridine,C9 H12 N2 O6,244.06949,Metabolic pathways;ABC transporters;Other,Other,pseudouridine,9,12,2,6,0,0,0,0,1.3333333333333333,0.6666666666666666,0.6666666666666665,41.3,5,-1,-3,0,-3,Tannin,1920978.4334294167,723071.8788105649,0.37640811902281723,-1.4096303479377343,1.2113295392887284e-5,4.101729727096486e-5,Downregulated
Feature0235,"(6E,8R,10Z)-8-Hydroxy-3-oxo-6,10-hexadecadienoic acid",C16 H26 O4,282.18315,Other,NA,"(6E,8R,10Z)-8-Hydroxy-3-oxo-6,10-hexadecadienoic acid",16,26,0,4,0,0,0,0,1.625,0.25,-1.125,92.3625,4,0,0,0.14285714285714285,0,Lipid,96510.95500732404,2927883.1267883233,30.33731379578755,4.9230214433245605,0.00504140194541803,0.010709065002068113,Upregulated
Feature0234,"2,4,6-Trihydroxyacetophenone",C8 H8 O4,168.0422,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"2,4,6-Trihydroxyacetophenone-peak2",8,8,0,4,0,0,0,0,1,0.5,0,60.3,5,1,0.25,0.5,1,Lignin,8890585.327176897,2620174.5869132406,0.29471339518038764,-1.7626154602105488,0.03239928355873416,0.05831871040572149,Downregulated
Feature0233,NA,C12 H15 N3 O9 P2,407.02843,NA,NA,Feature0233,12,15,3,9,0,2,0,0,1.25,0.75,0.16666666666666652,55.55,8,-1,3,-0.6,-6,Tannin,176187.52113983728,839591.4156125914,4.765328498754579,2.252575669998553,0.0025094020842027303,0.005646154689456143,Upregulated
Feature0232,cis-trihomoaconitic acid,C9 H12 O6,216.06335,Metabolic pathways;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Other,NA,cis-trihomoaconitic acid-peak1,9,12,0,6,0,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,4,-2,-0.6666666666666666,0.16666666666666666,-2,Tannin,3512773.1304414645,3297370.5225538304,0.938680182326331,-0.09129439383956177,0.6737757600731316,0.7246267608333679,Downregulated
Feature0231,Pyrogallol,C6 H6 O3,126.03174,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,Pyrogallol,6,6,0,3,0,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,3129494.2635312295,4325847.549607446,1.3822832653881547,0.46705329133749085,0.08979393546487784,0.14350245761209449,Upregulated
Feature0230,NA,C27 H37 N O7,487.25721,NA,NA,Feature0230,27,37,1,7,0,0,0,0,1.3703703703703705,0.25925925925925924,-0.7407407407407405,81.4111111111111,10,3,0.10526315789473684,0.24444444444444444,2,Lignin,84112.90669183143,95314.04222299915,1.1331678570115984,0.18036158449574013,0.20326001845464323,0.2860696556028312,Upregulated
Feature0229,NA,C10 H20 O9,284.11082,NA,NA,Feature0229,10,20,0,9,0,0,0,0,2,0.9,-0.20000000000000015,66,1,-8,-8,-0.6363636363636364,-8,Carbohydrate,325361.76907577337,756615.173704308,2.3254581380398758,1.2175149692816323,0.02594842077900806,0.04804250232958342,Upregulated
Feature0228,5-Aminonicotinic acid,C6 H6 N2 O2,138.04298,Metabolic pathways;Other,NA,5-Aminonicotinic acid,6,6,2,2,0,0,0,0,1,0.3333333333333333,0.6666666666666665,41.3,5,3,0.5,0.6666666666666666,1,Lignin,3806814.000462996,2250682.954737234,0.5912248285478353,-0.7582212380036178,0.0828160059298999,0.134871781085837,Downregulated
Feature0227,NA,C27 H37 N O6,471.26226,NA,NA,Feature0227,27,37,1,6,0,0,0,0,1.3703703703703705,0.2222222222222222,-0.8148148148148149,83.52222222222223,10,4,0.15,0.2608695652173913,3,Lignin,84612.0814351961,78096.23004490406,0.9229914773426005,-0.11561076841645634,0.4374157887567871,0.5088306114109564,Downregulated
Feature0226,2-[3-carboxylato-3-(methylammonio)propyl]-L-histidine dizwitterion,C11 H18 N4 O4,270.13292,NA,NA,2-[3-carboxylato-3-(methylammonio)propyl]-L-histidine dizwitterion,11,18,4,4,0,0,0,0,1.6363636363636365,0.3636363636363637,0.18181818181818168,55.11818181818182,5,1,-1,-0.2,-3,Protein,296248.2689990136,1260030.0968355336,4.253291001810813,2.0885795646996645,3.003785250033592e-5,9.254905905508905e-5,Upregulated
Feature0225,UNII:74D1OHC38H,C19 H32 O4,324.23021,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,UNII:74D1OHC38H,19,32,0,4,0,0,0,0,1.6842105263157894,0.21052631578947367,-1.2631578947368425,96.3,4,0,0,0.1176470588235294,0,Lipid,83147.54909911833,541433.8206101523,6.511723153315334,2.7030393645566604,0.002665756976519195,0.005958750888689965,Upregulated
Feature0224,val-phe,C14 H20 N2 O3,264.14747,Metabolic pathways;Other,NA,val-phe,14,20,2,3,0,0,0,0,1.4285714285714286,0.21428571428571427,-0.5714285714285712,76.58571428571427,6,3,0.1111111111111111,0.23809523809523808,1,Lignin,3894622.8676481107,837492.2943979873,0.2150380981313688,-2.2173358112775468,1.7365536208371014e-6,8.135634771592996e-6,Downregulated
Feature0223,(-)-Shikimic acid,C7 H10 O5,174.05282,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Degradation of aromatic compounds;Biosynthesis of amino acids;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant hormones;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Superpathway of chorismate metabolism;Other,(-)-Shikimic acid-peak1,7,10,0,5,0,0,0,0,1.4285714285714286,0.7142857142857143,0,60.3,3,-2,-1,0.1111111111111111,-2,Tannin,221118.34258686006,1116857.7197778074,5.050950123412225,2.336554795667133,7.606970361893766e-5,2.1862049275358554e-4,Upregulated
Feature0222,NP-008177,C28 H41 N O5,471.29858,NA,NA,NP-008177,28,41,1,5,0,0,0,0,1.4642857142857142,0.17857142857142858,-1,88.8,9,4,0.13636363636363635,0.22448979591836735,3,Lignin,132508.40917589676,142700.6678635922,1.0769178254503522,0.10690816878810576,0.556511358720179,0.615944610622334,Upregulated
Feature0221,D-(-)-Mannitol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Galactose metabolism;Fructose and mannose metabolism;Phosphotransferase system (PTS);Other,Other,D-(-)-Mannitol,6,14,0,6,0,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,523645.83334284445,5349332.269997669,10.215553966788319,3.3526955352255974,2.9293505657752423e-10,1.001837893495133e-8,Upregulated
Feature0220,2271703,C10 H17 N O5,231.11056,NA,NA,2271703,10,17,1,5,0,0,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,239852.67754726598,1279860.5146564215,5.336027630561718,2.415766136981861,2.5984534984136683e-9,5.4470897539881624e-8,Upregulated
Feature0219,2-Hydroxybenzyl alcohol,C7 H8 O2,124.05246,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Other,2-Hydroxybenzyl alcohol,7,8,0,2,0,0,0,0,1.1428571428571428,0.2857142857142857,-0.5714285714285712,76.58571428571427,4,2,0.4,0.5,2,Lignin,271906.1456356727,1728589.9914634814,6.357303868297337,2.6684150484451377,0.07202441404103967,0.11957451263124061,Upregulated
Feature0218,2'-Deoxyinosine,C10 H12 N4 O4,252.08587,Metabolic pathways;ABC transporters;Other,Other,2'-Deoxyinosine,10,12,4,4,0,0,0,0,1.2,0.4,0.7999999999999998,37.5,7,3,-0.5,0.25,-1,Lignin,5310853.14015346,764893.6719230523,0.14402463252842843,-2.7956125180290137,2.393288707380037e-4,6.394568265031036e-4,Downregulated
Feature0217,S-inosyl-L-homocysteine,C14 H19 N5 O6 S,385.10554,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,S-inosyl-L-homocysteine,14,19,5,6,1,0,0,0,1.3571428571428572,0.42857142857142855,0.7142857142857144,39.942857142857136,8,2,-2,-0.2,-4,Lignin,614211.9674392759,255153.73174475261,0.4154164120385336,-1.2673698803926277,4.327344321190171e-8,4.598610930610979e-7,Downregulated
Feature0216,asp-leu,C10 H18 N2 O5,246.12157,Metabolic pathways;Other,NA,asp-leu-peak1,10,18,2,5,0,0,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,1350325.5458057856,1005064.3316839095,0.7443126102484814,-0.4260194163873797,0.03508571002784248,0.06217260533431154,Downregulated
Feature0215,lys-leu,C12 H25 N3 O3,259.18964,NA,NA,lys-leu,12,25,3,3,0,0,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,1949326.379095928,574977.4377716541,0.29496211816428664,-1.7613984131106242,9.021681152428415e-8,7.175383614257019e-7,Downregulated
Feature0214,2-Aminooctanedioic acid,C8 H15 N O4,189.10013,NA,NA,2-Aminooctanedioic acid-peak2,8,15,1,4,0,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,1749683.147290473,2746687.214495994,1.569819780655408,0.6505989435254581,0.021020988387683206,0.03993987793659809,Upregulated
Feature0213,beta-D-Xylopyranosyl-(1->4)-beta-D-xylopyranosyl-(1->4)-beta-D-xylopyranosyl-(1->4)-beta-D-xylopyranose,C20 H34 O17,546.17964,ABC transporters,NA,beta-D-Xylopyranosyl-(1->4)-beta-D-xylopyranosyl-(1->4)-beta-D-xylopyranosyl-(1->4)-beta-D-xylopyranose,20,34,0,17,0,0,0,0,1.7,0.85,0,60.3,4,-13,-4.333333333333333,-0.391304347826087,-13,Carbohydrate,9341899.834023805,717374.2924333038,0.0767910494844507,-3.702918024881782,6.446020472825207e-8,6.276823240279669e-7,Downregulated
Feature0212,N-Acetylalanine,C5 H9 N O3,131.05829,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;ABC transporters;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Biosynthesis of amino acids;Other,Other,N-Acetylalanine,5,9,1,3,0,0,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,4933358.826873069,2443227.7634077487,0.4952463117215315,-1.0137818640045437,2.524979052365713e-6,1.0906228443736321e-5,Downregulated
Feature0211,Threonylleucine,C10 H20 N2 O4,232.14232,Other,NA,Threonylleucine,10,20,2,4,0,0,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,2167020.88003514,2708083.512779375,1.2496803965891927,0.32155917551753843,0.17066501512993146,0.24421520993488102,Upregulated
Feature0210,2-Hydroxy-3-[4-(sulfooxy)phenyl]propanoic acid,C9 H10 O7 S,262.01468,NA,NA,2-Hydroxy-3-[4-(sulfooxy)phenyl]propanoic acid,9,10,0,7,1,0,0,0,1.1111111111111112,0.7777777777777778,0.6666666666666665,41.3,5,-2,-3,0.1111111111111111,-3,Tannin,336539.10182787024,1486710.1407166529,4.417644584661253,2.1432773533757046,4.095828834337422e-6,1.6288063503993006e-5,Upregulated
Feature0209,3-[(2Z)-1-Oxo-2-buten-2-yl]pentanedioic acid,C9 H12 O5,200.06848,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,3-[(2Z)-1-Oxo-2-buten-2-yl]pentanedioic acid-peak2,9,12,0,5,0,0,0,0,1.3333333333333333,0.5555555555555556,-0.22222222222222232,66.63333333333333,4,-1,-0.25,0.2307692307692308,-1,Lignin,1478834.8570971647,282424.5456453446,0.19097774460072,-2.3885235698458356,0.2914159859988343,0.38779870510350706,Downregulated
Feature0208,Loganetin,C11 H16 O5,228.09967,NA,NA,Loganetin,11,16,0,5,0,0,0,0,1.4545454545454546,0.4545454545454546,-0.5454545454545459,75.84545454545456,4,-1,-0.16666666666666666,0.17647058823529413,-1,Lignin,3005846.268754956,638082.8271773965,0.21228059259387713,-2.2359556136507175,0.10650885782221947,0.16482366233121748,Downregulated
Feature0207,3-Hydroxybutyric acid,C4 H8 O3,104.04737,Metabolic pathways;Microbial metabolism in diverse environments;Carbon metabolism;Other,NA,3-Hydroxybutyric acid-peak2,4,8,0,3,0,0,0,0,2,0.75,-0.5,74.55,1,-2,-2,-0.2,-2,Carbohydrate,1028643.6268570948,988815.879910715,0.9612812971309909,-0.05696943018154326,0.754581494709696,0.7989686414573253,Downregulated
Feature0206,N-(2-Cyanoethyl)-L-glutamine,C8 H13 N3 O3,199.09571,Other,NA,N-(2-Cyanoethyl)-L-glutamine,8,13,3,3,0,0,0,0,1.625,0.375,0.25,53.175,4,1,-1,-0.14285714285714285,-2,Protein,247359.2896094361,7766050.6952334475,31.39583197985217,4.972501138681771,1.97409610950927e-6,8.655652172463724e-6,Upregulated
Feature0205,NA,C6 H3 N2 O4 P3,259.93046,NA,NA,Feature0205,6,3,2,4,0,3,0,0,0.5,0.6666666666666666,-0.666666666666667,79.30000000000001,8,4,0.3333333333333333,-1,-1,Condensed HC,2764718.79983943,1625697.8844070816,0.5880156363466329,-0.7660735755743487,0.3048776865581512,0.4000269816340934,Downregulated
Feature0204,Miglitol,C8 H17 N O5,207.11059,NA,NA,Miglitol,8,17,1,5,0,0,0,0,2.125,0.625,-0.5,74.55,1,-4,-2.5,-0.5555555555555556,-5,Amino Sugar,212866.82773698852,7904767.267999555,37.13480090832393,5.214699938463736,3.826388494902553e-12,4.3620828841889107e-10,Upregulated
Feature0203,Cystathionine,C7 H14 N2 O4 S,222.06744,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;Other,Other,Cystathionine,7,14,2,4,1,0,0,0,2,0.5714285714285714,0.2857142857142856,52.15714285714286,2,-2,-Inf,-1.5,-5,Amino Sugar,332073.93504513806,5400979.844605491,16.26438956695396,4.023644771231689,8.077600743868352e-8,6.577474891435658e-7,Upregulated
Feature0202,methylguanosine,C11 H15 N5 O5,297.10742,NA,NA,methylguanosine,11,15,5,5,0,0,0,0,1.3636363636363635,0.4545454545454546,0.9090909090909092,34.39090909090909,7,2,-3,-0.14285714285714285,-3,Lignin,9396407.801045677,7038722.458668435,0.7490865240954243,-0.41679572643842977,0.0034182937304741926,0.007399091492545405,Downregulated
Feature0201,melizame,C7 H6 N4 O2,178.04906,NA,NA,melizame,7,6,4,2,0,0,0,0,0.8571428571428571,0.2857142857142857,1.4285714285714284,19.58571428571429,7,5,1,1,1,Lignin,411685.8226220112,465696.358015355,1.131193576328067,0.17784583269810778,0.28574143979733907,0.3832296957281959,Upregulated
Feature0200,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11117,NA,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,1,8,0,0,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,760268.9574074625,26134898.127290264,34.375858533552346,5.103323840023115,1.0801629621862705e-5,3.7314720511889344e-5,Upregulated
Feature0199,"1,5-Anhydro-D-glucitol",C6 H12 O5,164.06849,Metabolic pathways;Microbial metabolism in diverse environments;ABC transporters;Fructose and mannose metabolism;Other,Other,"1,5-Anhydro-D-glucitol",6,12,0,5,0,0,0,0,2,0.8333333333333334,-0.33333333333333304,69.79999999999998,1,-4,-4,-0.42857142857142855,-4,Carbohydrate,915882.1615088957,682767.0360303262,0.7454747616281581,-0.42376858461908634,0.449742106037186,0.5196344603537758,Downregulated
Feature0198,NA,C7 H6 N4 O5 P2,287.98122,NA,NA,Feature0198,7,6,4,5,0,2,0,0,0.8571428571428571,0.7142857142857143,0.8571428571428572,35.87142857142857,8,3,0.75,0.3333333333333333,-3,Tannin,1689571.765576753,8054266.358088584,4.767046018515334,2.253095552481935,7.60458447077704e-7,4.128202998421822e-6,Upregulated
Feature0197,NA,C18 H28 O15,484.143,NA,NA,Feature0197,18,28,0,15,0,0,0,0,1.5555555555555556,0.8333333333333334,0.11111111111111116,57.133333333333326,5,-10,-3.3333333333333335,-0.23809523809523808,-10,Carbohydrate,6619917.465541152,170035.45280826752,0.025685433948891053,-5.282905741917201,4.4750522592303306e-6,1.7391680371099693e-5,Downregulated
Feature0196,NA,C31 H34 O11,582.21017,NA,NA,Feature0196,31,34,0,11,0,0,0,0,1.096774193548387,0.3548387096774194,-0.387096774193548,71.33225806451611,15,4,0.2,0.37254901960784315,4,Lignin,94050.74207397013,128721.285532521,1.3686365752572454,0.4527394073845986,0.02757261067710125,0.05042691364475202,Upregulated
Feature0195,NA,C11 H23 N O7,281.14757,NA,NA,Feature0195,11,23,1,7,0,0,0,0,2.090909090909091,0.6363636363636364,-0.5454545454545459,75.84545454545456,1,-6,-2.3333333333333335,-0.5384615384615384,-7,Amino Sugar,4235628.918394361,255954.99932559667,0.06042904235874939,-4.048614110474694,1.373628094659699e-4,3.758246466988937e-4,Downregulated
Feature0194,Glu-Gly,C7 H12 N2 O5,204.07461,NA,NA,Glu-Gly,7,12,2,5,0,0,0,0,1.7142857142857142,0.7142857142857143,0.5714285714285716,44.014285714285705,3,-2,-Inf,-0.6,-4,Carbohydrate,5136199.710539281,2942481.933746402,0.5728908725469813,-0.8036677423434769,0.0024985770966014917,0.005646154689456143,Downregulated
Feature0193,NA,C6 H14 O7,198.07397,NA,NA,Feature0193,6,14,0,7,0,0,0,0,2.3333333333333335,1.1666666666666667,0,60.3,0,-7,7,-1.4,-7,Carbohydrate,5446747.724302288,230038713.9995624,42.234141481011896,5.400337819676568,1.1366448084390729e-7,8.270904776301338e-7,Upregulated
Feature0192,Glycolic acid,C2 H4 O3,76.01606,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Carbon metabolism;Other,Other,Glycolic acid-peak1,2,4,0,3,0,0,0,0,2,1.5,1,31.799999999999997,1,-2,2,-1,-2,Carbohydrate,6864431.300594737,5642983.313033402,0.8220612991704778,-0.2826821186057756,0.12489898174986327,0.18571935547153584,Downregulated
Feature0191,L-glycero-ÃÂ±-D-manno-Heptopyranose,C7 H14 O7,210.07387,Metabolic pathways;Other,NA,L-glycero-ÃÂ±-D-manno-Heptopyranose,7,14,0,7,0,0,0,0,2,1,0,60.3,1,-6,-Inf,-0.7142857142857143,-6,Carbohydrate,1184641.7135598944,991238.3985961197,0.8367410899430595,-0.25714681146543195,0.35431229212884097,0.4312270601710449,Downregulated
Feature0190,NP-001596,C16 H30 O4,286.21438,Metabolic pathways;Other,NA,NP-001596,16,30,0,4,0,0,0,0,1.875,0.25,-1.375,99.4875,2,-2,-0.16666666666666666,0,-2,Lipid,439662.99467508186,220911.64055357256,0.5024567526244275,-0.9929286686641011,0.4173607263976534,0.4921978221655085,Downregulated
Feature0189,3-Hydroxybutyric acid,C4 H8 O3,104.04736,Metabolic pathways;Microbial metabolism in diverse environments;Carbon metabolism;Other,NA,3-Hydroxybutyric acid-peak1,4,8,0,3,0,0,0,0,2,0.75,-0.5,74.55,1,-2,-2,-0.2,-2,Carbohydrate,1307685.7421905373,1507102.3430234455,1.1524958133281016,0.20476150978541016,0.665169276660569,0.717627421507617,Upregulated
Feature0188,(2S)-5-Carbamimidamido-2-(2-oxo-1-azetidinyl)pentanoic acid,C9 H16 N4 O3,228.12222,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,(2S)-5-Carbamimidamido-2-(2-oxo-1-azetidinyl)pentanoic acid,9,16,4,3,0,0,0,0,1.7777777777777777,0.3333333333333333,0.22222222222222232,53.96666666666666,4,1,-1.5,-0.42857142857142855,-3,Protein,2481869.4751488008,4096458.0730135986,1.6505533888997104,0.7229498048162062,4.850085491156266e-5,1.4810082481923596e-4,Upregulated
Feature0187,2'-O-Methylinosine,C11 H14 N4 O5,282.09642,ABC transporters,NA,2'-O-Methylinosine,11,14,4,5,0,0,0,0,1.2727272727272727,0.4545454545454546,0.7272727272727271,39.57272727272728,7,2,-1,0.1111111111111111,-2,Lignin,6567639.576873186,261632.64534807033,0.03983663267231727,-4.64976048594965,1.606429317679461e-7,1.0772526012674032e-6,Downregulated
Feature0186,NP-011548,C18 H34 O3,298.25084,Other,NA,NP-011548,18,34,0,3,0,0,0,0,1.8888888888888888,0.16666666666666666,-1.5555555555555554,104.63333333333333,2,-1,-0.06666666666666667,0.0303030303030303,-1,Lipid,338461.12337766506,731345.8115713889,2.1607970932464564,1.111563604214542,0.16645173984268868,0.23918695389159467,Upregulated
Feature0185,4-Dodecylbenzenesulfonic acid,C18 H30 O3 S,326.19169,NA,NA,4-Dodecylbenzenesulfonic acid,18,30,0,3,1,0,0,0,1.6666666666666667,0.16666666666666666,-1.2222222222222223,95.13333333333333,4,1,0,0.0967741935483871,0,Lipid,2615724.1823252738,3005845.095940301,1.1491445146438282,0.20056024049900562,0.7081016877532784,0.7544260972324648,Upregulated
Feature0184,NA,C7 H18 N O7 P,259.0822,NA,NA,Feature0184,7,18,1,7,0,1,0,0,2.5714285714285716,1,-0.8571428571428568,84.72857142857141,0,-7,4.5,-3.6666666666666665,-9,Other,309745.3063078486,1942599.8773472763,6.2716039203401905,2.6488344497266305,1.0331633385559258e-5,3.619404177742227e-5,Upregulated
Feature0183,Valylvaline,C10 H20 N2 O3,216.1473,NA,NA,Valylvaline,10,20,2,3,0,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.2307692307692308,-3,Lipid,3722527.623584522,2051864.2895177973,0.5512018974736317,-0.859347240460748,0.0010589938082285143,0.0025505343831982528,Downregulated
Feature0182,NA,C30 H52 O6 S,540.34851,NA,NA,Feature0182,30,52,0,6,1,0,0,0,1.7333333333333334,0.2,-1.2666666666666666,96.4,5,-1,-0.08695652173913043,0.03846153846153846,-2,Lipid,63165.55863964275,4891973.347204127,77.44684686654415,6.275134597909929,1.4821750425746395e-5,4.9322664002252263e-5,Upregulated
Feature0181,"Î±,Î±-Trehalose",C12 H22 O11,342.11625,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Galactose metabolism;Phosphotransferase system (PTS);Other,Superpathway of anaerobic sucrose degradation;Chitin biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Other,"Î±,Î±-Trehalose-peak3",12,22,0,11,0,0,0,0,1.8333333333333333,0.9166666666666666,0,60.3,2,-9,-9,-0.5384615384615384,-9,Carbohydrate,9056310.042443886,996412.379361739,0.11002410194570289,-3.1841084988764985,5.162636572139362e-5,1.5487909716418085e-4,Downregulated
Feature0180,Adenosine 5'-monophosphate,C10 H14 N5 O7 P,347.06322,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Biosynthesis of plant hormones;Other,Superpathway of anaerobic sucrose degradation;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Methanobacterium thermoautotrophicumÂ biosynthetic metabolism;Superpathway of coenzyme A biosynthesis II (plants);Superpathway of purine nucleotide salvage;Superpathway of chorismate metabolism;Other,Adenosine 5'-monophosphate,10,14,5,7,0,1,0,0,1.4,0.7,1,31.799999999999997,7,0,2,-5,-6,Tannin,2852016.33341361,273253.0633489037,0.09581048332280907,-3.3836726694043757,6.13992247604783e-4,0.0015327397713929619,Downregulated
Feature0179,16-Hydroxyhexadecanoic acid,C16 H32 O3,272.23521,Metabolic pathways;Other,NA,16-Hydroxyhexadecanoic acid,16,32,0,3,0,0,0,0,2,0.1875,-1.625,106.6125,1,-2,-0.15384615384615383,-0.03448275862068965,-2,Lipid,985151.2897907385,448134.7710871398,0.45488929033664527,-1.1364126258768155,0.11390353529109702,0.17236729676794327,Downregulated
Feature0178,Sorbic acid,C6 H8 O2,112.05247,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,Sorbic acid,6,8,0,2,0,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Lignin,615515.9836729156,624139.9126432106,1.014010893622671,0.02007315144478827,0.9025329909363897,0.9186496514888252,Upregulated
Feature0177,4-Undecylbenzenesulfonic acid,C17 H28 O3 S,312.17592,NA,NA,4-Undecylbenzenesulfonic acid-peak1,17,28,0,3,1,0,0,0,1.6470588235294117,0.17647058823529413,-1.1764705882352944,93.8294117647059,4,1,0,0.10344827586206896,0,Lipid,2615086.2965876358,2243226.00267563,0.857801903364628,-0.2212835777345234,0.41098385321326025,0.48804332569074654,Downregulated
Feature0176,4-Carboxy-2-[(5-oxidanidyl-5-oxidanylidenenorvalyl)amino]butanoate,C10 H14 N2 O7,274.08009,NA,NA,4-Carboxy-2-[(5-oxidanidyl-5-oxidanylidenenorvalyl)amino]butanoate,10,14,2,7,0,0,0,0,1.4,0.7,0.6000000000000001,43.2,5,-2,-4,-0.1111111111111111,-4,Tannin,17371522.430159803,24895711.068361707,1.4331335188641083,0.5191730255314768,0.0016966327799086175,0.0040017131774396355,Upregulated
Feature0175,Guanine,C5 H5 N5 O,151.04944,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Guanine,5,5,5,1,0,0,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Lignin,5327469.413106058,400143.6780483526,0.07510952142943568,-3.7348603839217063,1.7551231219554392e-4,4.763905616736192e-4,Downregulated
Feature0174,N-Acetyl-L-methionine,C7 H13 N O3 S,191.0616,NA,NA,N-Acetyl-L-methionine,7,13,1,3,1,0,0,0,1.8571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,832018.0922906125,596526.7995889947,0.7169637356643395,-0.4800279462535426,0.3066624790877278,0.40029987728245386,Downregulated
Feature0173,Pyrrole-2-carboxylic acid,C5 H5 N O2,111.03207,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,Pyrrole-2-carboxylic acid,5,5,1,2,0,0,0,0,1,0.4,0.3999999999999999,48.9,4,2,0.5,0.6666666666666666,1,Lignin,832791.9934082745,3055431.2850839403,3.6689008891395787,1.875347932474677,1.87303484940897e-6,8.541038913304902e-6,Upregulated
Feature0172,"2,4-Dinitrophenol",C6 H4 N2 O5,184.01199,NA,NA,"2,4-Dinitrophenol",6,4,2,5,0,0,0,0,0.6666666666666666,0.8333333333333334,2,3.299999999999997,6,1,1,1,-1,Condensed HC,365662.68952297914,863370.0726140687,2.3611106556711263,1.2394656564107005,7.247924392368722e-8,6.52313195313185e-7,Upregulated
Feature0171,NA,C10 H N2 O4 P,243.96742,NA,NA,Feature0171,10,1,2,4,0,1,0,0,0.1,0.4,0.7999999999999998,37.5,12,8,1.6666666666666667,1.4,5,Other,7643130.622467683,124321.9430754141,0.016265840427999275,-5.942010823898427,0.3307362011235515,0.4174532400169051,Downregulated
Feature0170,NA,C9 H2 N3 O3 P,230.98339000000001,NA,NA,Feature0170,9,2,3,3,0,1,0,0,0.2222222222222222,0.3333333333333333,0.8888888888888888,34.96666666666667,11,8,2,1.5714285714285714,4,Condensed HC,22798365.740765847,4049081.542994029,0.17760402605322934,-2.49326380880073,0.4130156146229992,0.48875896263344537,Downregulated
Feature0169,"(2R)-2,3-Dihydroxypropanoic acid",C3 H6 O4,106.02664,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Carbon metabolism;Other,Superpathway of microbial D-galacturonate and D-glucuronate degradation;Other,"(2R)-2,3-Dihydroxypropanoic acid",3,6,0,4,0,0,0,0,2,1.3333333333333333,0.6666666666666665,41.3,1,-3,3,-1,-3,Carbohydrate,3526583.233185182,1169995.7289818812,0.3317646718138424,-1.5917678267748616,0.05162804091268683,0.08917570703100453,Downregulated
Feature0168,2-Aminooctanedioic acid,C8 H15 N O4,189.10017,NA,NA,2-Aminooctanedioic acid-peak1,8,15,1,4,0,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,1818724.3272137986,1620024.181946904,0.890747518854991,-0.1669115350980669,0.342876117032625,0.42333441164316876,Downregulated
Feature0167,beta-D-Ethyl glucuronide,C8 H14 O7,222.07389,NA,NA,beta-D-Ethyl glucuronide-peak4,8,14,0,7,0,0,0,0,1.75,0.875,0,60.3,2,-5,-5,-0.3333333333333333,-5,Carbohydrate,16504615.13926009,360963.4828627158,0.0218704574336956,-5.514872794243651,3.227066290044987e-4,8.456586698345456e-4,Downregulated
Feature0166,2-Keto-4-methylthiobutyric acid,C5 H8 O3 S,148.01946,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Other,Other,2-Keto-4-methylthiobutyric acid,5,8,0,3,1,0,0,0,1.6,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,398213.75314655073,405637.2840845288,1.0186420757176764,0.026647215098465505,0.8784229537025012,0.9021641146133796,Upregulated
Feature0165,2-Hydroxycinnamic acid,C9 H8 O3,164.04733,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Degradation of aromatic compounds;Biosynthesis of amino acids;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Other,Superpathway of scopolin and esculin biosynthesis;Superpathway of chorismate metabolism;Other,2-Hydroxycinnamic acid,9,8,0,3,0,0,0,0,0.8888888888888888,0.3333333333333333,-0.22222222222222232,66.63333333333333,6,3,0.5,0.6,3,Lignin,134077.65944135858,174561.37918125803,1.3019423214022152,0.38066553570001266,0.2055687842824008,0.2881332960023814,Upregulated
Feature0164,N-Acetylglucosaminitol,C8 H17 N O6,223.10558,NA,NA,N-Acetylglucosaminitol-peak2,8,17,1,6,0,0,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,512341.84479869145,5772807.396639101,11.267491529815105,3.4940944604144897,2.586065201643472e-6,1.091894196249466e-5,Upregulated
Feature0163,MFCD00025555,C9 H18 N2 O3,202.13173,NA,NA,MFCD00025555,9,18,2,3,0,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,49821940.52883249,3952139.9566808743,0.07932529152279263,-3.656075271675122,1.1119782904202005e-4,3.0918420758025084e-4,Downregulated
Feature0162,NA,C5 H13 O6 P,200.045,NA,NA,Feature0162,5,13,0,6,0,1,0,0,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,3164494.401420833,4550645.587929403,1.4380324344660553,0.5240962157741684,0.5914837306198893,0.6492757090591638,Upregulated
Feature0161,NA,C8 H16 O7,224.08956,NA,NA,Feature0161,8,16,0,7,0,0,0,0,2,0.875,-0.25,67.425,1,-6,-6,-0.5555555555555556,-6,Carbohydrate,3660259.6659161327,3196797.33226685,0.8733799304008444,-0.1953187154108772,0.8223699623878614,0.8560291268696524,Downregulated
Feature0160,ascopyrone P,C6 H8 O4,144.04231,Microbial metabolism in diverse environments;Other,Other,ascopyrone P,6,8,0,4,0,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,80496677.79811627,4567091.866857992,0.05673640194583121,-4.139581527697847,8.256133489252775e-6,3.0361265089510204e-5,Downregulated
Feature0159,NA,C8 H11 N O5,201.06374,NA,NA,Feature0159,8,11,1,5,0,0,0,0,1.375,0.625,0.25,53.175,4,-1,-1,0.1111111111111111,-2,Lignin,37033499.24268002,45004428.36653258,1.215235645749249,0.2812360932471044,0.08780321849965621,0.1416448147494454,Upregulated
Feature0158,NA,C10 H24 N6 O5 P2,370.12836,NA,NA,Feature0158,10,24,6,5,0,2,0,0,2.4,0.5,-0.5999999999999996,77.39999999999999,3,-2,3.3333333333333335,15,-10,Other,4211881.395183466,2327339.3651016294,0.552565266382638,-0.8557832160384711,0.5011868014352225,0.565695993699162,Downregulated
Feature0157,3-Hydroxy-3-methylglutaric acid,C6 H10 O5,162.05278,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Fructose and mannose metabolism;Other,Superpathway of butirocin biosynthesis;Other,3-Hydroxy-3-methylglutaric acid,6,10,0,5,0,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,83363230.61568108,2312549.9074869067,0.02774064645056958,-5.171854782064035,8.418167761501205e-7,4.498458397552206e-6,Downregulated
Feature0156,.alpha.-Glucoheptitol,C7 H16 O7,212.08955,NA,NA,.alpha.-Glucoheptitol-peak2,7,16,0,7,0,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,411725.7010685734,29455572.68831832,71.54173910414318,6.1607132840400025,5.4861929853009026e-5,1.6315460878025292e-4,Upregulated
Feature0155,NA,C18 H32 O17,520.16402,NA,NA,Feature0155,18,32,0,17,0,0,0,0,1.7777777777777777,0.9444444444444444,0.11111111111111116,57.133333333333326,3,-14,-14,-0.5789473684210527,-14,Carbohydrate,17162970.43389662,849182.1879935462,0.0494775768136513,-4.337081344362102,0.09574431952900768,0.15089657732221487,Downregulated
Feature0154,NA,C12 H23 N O14,405.11204,NA,NA,Feature0154,12,23,1,14,0,0,0,0,1.9166666666666667,1.1666666666666667,0.6666666666666665,41.3,2,-12,4.333333333333333,-1.5,-13,Carbohydrate,749449712.2475115,1046921.5559019272,0.001396920352083841,-9.483534519411798,9.57302206124298e-6,3.4103891093178116e-5,Downregulated
Feature0153,beta-D-Ethyl glucuronide,C8 H14 O7,222.07391,NA,NA,beta-D-Ethyl glucuronide-peak3,8,14,0,7,0,0,0,0,1.75,0.875,0,60.3,2,-5,-5,-0.3333333333333333,-5,Carbohydrate,43405482.287014954,5463314.502161981,0.12586692312358821,-2.9900288913794846,1.4250404975429307e-7,9.946201023666986e-7,Downregulated
Feature0152,4-Acetamidobutanoic acid,C6 H11 N O3,145.07394,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Biosynthesis of amino acids;Other,Superpathway of L-lysine degradation;Other,4-Acetamidobutanoic acid,6,11,1,3,0,0,0,0,1.8333333333333333,0.5,-0.33333333333333304,69.79999999999998,2,-1,-1,-0.14285714285714285,-2,Protein,3290619.3228031835,2245841.281928735,0.6824980532891199,-0.5511031638939025,0.48334696381581166,0.5491849223422178,Downregulated
Feature0151,3-Phenyllactic acid,C9 H10 O3,166.06292,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,3-Phenyllactic acid,9,10,0,3,0,0,0,0,1.1111111111111112,0.3333333333333333,-0.44444444444444464,72.96666666666667,5,2,0.3333333333333333,0.4666666666666667,2,Lignin,6824706.964806694,9012001.46447637,1.32049647126961,0.40108044623152117,0.3884846240203741,0.4661815488244489,Upregulated
Feature0150,Mevalonic acid,C6 H12 O4,148.07362,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant hormones;Biosynthesis of terpenoids and steroids;Other,Superpathway of branched chain amino acid biosynthesis;Methanobacterium thermoautotrophicumÂ biosynthetic metabolism;Superpathway of L-threonine metabolism;Superpathway of coenzyme A biosynthesis II (plants);Superpathway of L-isoleucine biosynthesis I;Other,Mevalonic acid-peak1,6,12,0,4,0,0,0,0,2,0.6666666666666666,-0.666666666666667,79.30000000000001,1,-3,-1.5,-0.25,-3,Amino Sugar,251806.7301769942,4613756.230282568,18.322608879594174,4.195553032256878,9.313538480655813e-5,2.632421620152304e-4,Upregulated
Feature0149,N-Acetylvaline,C7 H13 N O3,159.08948,Metabolic pathways;Other,Superpathway of L-lysine degradation,N-Acetylvaline,7,13,1,3,0,0,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,1727764.807191824,1710607.1596583251,0.9900694542092302,-0.014398359868304842,0.9888030608070424,0.9888030608070424,Downregulated
Feature0148,"6-(1-Hydroxyethyl)-3-(hydroxymethyl)-2,7-dioxabicyclo[4.1.0]hept-3-en-5-one",C8 H10 O5,186.05291,NA,NA,"6-(1-Hydroxyethyl)-3-(hydroxymethyl)-2,7-dioxabicyclo[4.1.0]hept-3-en-5-one-peak1",8,10,0,5,0,0,0,0,1.25,0.625,0,60.3,4,-1,-0.3333333333333333,0.2727272727272727,-1,Lignin,1513907.1955046211,1337270.565145095,0.8833240036879216,-0.1789853786727718,0.2845746414190893,0.3831674305721596,Downregulated
Feature0147,Acrylic acid,C3 H4 O2,72.02116,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of L-threonine metabolism;Other,Acrylic acid-peak2,3,4,0,2,0,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,2,0,0,0.5,0,Tannin,90286277.48821837,1032940.2611701896,0.011440722664692649,-6.449678005504606,1.422424211325592e-6,6.949558289619322e-6,Downregulated
Feature0146,"5,7-Dihydroxy-2,2-dimethyl-3,4-dihydro-2H-chromen-4-yl hydrogen sulfate",C11 H14 O7 S,290.04605,NA,NA,"5,7-Dihydroxy-2,2-dimethyl-3,4-dihydro-2H-chromen-4-yl hydrogen sulfate",11,14,0,7,1,0,0,0,1.2727272727272727,0.6363636363636364,0.18181818181818168,55.11818181818182,5,-2,-1,0.07692307692307693,-3,Lignin,64771.89020560423,68862.67674004921,1.0631568188215548,0.08835441441340815,0.6095890144877902,0.666068507842889,Upregulated
Feature0145,DL-4-Hydroxyphenyllactic acid,C9 H10 O4,182.05791,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,DL-4-Hydroxyphenyllactic acid,9,10,0,4,0,0,0,0,1.1111111111111112,0.4444444444444444,-0.22222222222222232,66.63333333333333,5,1,0.2,0.42857142857142855,1,Lignin,3262712.951288212,10160390.258984987,3.114092600445704,1.6388118449363809,0.011045985269738079,0.022353413977813156,Upregulated
Feature0144,NA,C5 H12 N2 S2,164.04417,NA,NA,Feature0144,5,12,2,0,2,0,0,0,2.4,0,-0.4000000000000003,71.7,1,1,-3,-3,-3,Lipid,165741.48830770285,118651.5167783641,0.715883017522353,-0.4822042390025532,0.1152868970032132,0.17369215319426834,Downregulated
Feature0143,NA,C33 H38 O10,594.2465,NA,NA,Feature0143,33,38,0,10,0,0,0,0,1.1515151515151516,0.30303030303030304,-0.5454545454545459,75.84545454545456,15,5,0.21739130434782608,0.35714285714285715,5,Lignin,73996.49069401677,70877.55613229796,0.9578502367819587,-0.062127991683912344,0.8574117009978156,0.8832373546423281,Downregulated
Feature0142,"2-(3,4-Dimethoxyphenyl)-5,6,7,8-tetramethoxy-2,3-dihydro-4H-chromen-4-one",C21 H24 O8,404.14731,NA,NA,"2-(3,4-Dimethoxyphenyl)-5,6,7,8-tetramethoxy-2,3-dihydro-4H-chromen-4-one",21,24,0,8,0,0,0,0,1.1428571428571428,0.380952380952381,-0.3809523809523814,71.15714285714287,10,2,0.15384615384615383,0.35294117647058826,2,Lignin,463568.23879366275,248636.06056727786,0.5363526656060391,-0.8987461732838261,7.780553968833113e-4,0.0019282242444499454,Downregulated
Feature0141,.,C3 H6 O2,74.0368,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Fructose and mannose metabolism;Other,Superpathway of L-threonine metabolism;Superpathway of coenzyme A biosynthesis II (plants);Other,.,3,6,0,2,0,0,0,0,2,0.6666666666666666,-0.666666666666667,79.30000000000001,1,-1,-1,0,-1,Amino Sugar,6265911.72784518,3490719.8555726283,0.557096877069009,-0.8439998662195316,0.36420864910695583,0.441699851044606,Downregulated
Feature0140,D-(-)-Glutamine,C5 H10 N2 O3,146.06919,Metabolic pathways;Microbial metabolism in diverse environments;ABC transporters;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Biosynthesis of amino acids;Central carbon metabolism in cancer;Other,Chitin biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Superpathway of purine nucleotide salvage;Superpathway of chorismate metabolism;Superpathway of butirocin biosynthesis;Other,D-(-)-Glutamine,5,10,2,3,0,0,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,1538706.5570437848,21944215.977995813,14.26146907449058,3.8340506963968917,2.551164548242414e-6,1.0906228443736321e-5,Upregulated
Feature0139,"3,12-Dihydroxy-13-methoxypodocarpa-8,11,13-trien-7-one",C18 H24 O4,304.16748,NA,NA,"3,12-Dihydroxy-13-methoxypodocarpa-8,11,13-trien-7-one",18,24,0,4,0,0,0,0,1.3333333333333333,0.2222222222222222,-0.8888888888888893,85.63333333333334,7,3,0.21428571428571427,0.3125,3,Lignin,62151.25377636089,23020218.329656836,370.39024848139957,8.532902306049117,0.01609292904066269,0.03127148711310591,Upregulated
Feature0138,cis-Aconitic acid,C6 H6 O6,174.0164,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant hormones;Ascorbate and aldarate metabolism;Biosynthesis of terpenoids and steroids;Other,Superpathway of betalain biosynthesis;Other,cis-Aconitic acid,6,6,0,6,0,0,0,0,1,1,1,31.799999999999997,4,-2,-Inf,0.3333333333333333,-2,Tannin,5600531.86477261,10100801.92445698,1.8035433363018794,0.85083408922843,0.005130735664512999,0.010831553069527444,Upregulated
Feature0137,glutaral,C5 H8 O2,100.05245,NA,NA,glutaral,5,8,0,2,0,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,6585856.873735052,247387.4783025221,0.03756344588797914,-4.734526774880281,0.3353380892305142,0.4180231321125174,Downregulated
Feature0136,beta-D-Ethyl glucuronide,C8 H14 O7,222.07396,NA,NA,beta-D-Ethyl glucuronide-peak2,8,14,0,7,0,0,0,0,1.75,0.875,0,60.3,2,-5,-5,-0.3333333333333333,-5,Carbohydrate,71893090.91567935,1920536.3051429123,0.026713781264397655,-5.226271989717416,1.5116808621813259e-5,4.9322664002252263e-5,Downregulated
Feature0135,MS 3 (enzyme inhibitor),C21 H24 O7,388.15231,NA,NA,MS 3 (enzyme inhibitor),21,24,0,7,0,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Lignin,109629.5640343234,129509.16579225437,1.1813343137231391,0.24041730046544668,0.5291375451859819,0.5913890210902151,Upregulated
Feature0134,UDP-N-acetylglucosamine,C17 H27 N3 O17 P2,607.08161,Metabolic pathways;Other,Chitin biosynthesis;Superpathway of CMP-sialic acids biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Superpathway of butirocin biosynthesis;Other,UDP-N-acetylglucosamine,17,27,3,17,0,2,0,0,1.588235294117647,1,0.3529411764705883,50.24117647058823,7,-10,3,-1.8571428571428572,-15,Carbohydrate,2715898.410636566,24932654.600631807,9.1802603893376,3.198535074889448,7.145490099922894e-11,3.740731460271782e-9,Upregulated
Feature0133,NA,C4 H11 O6 P,186.02928,NA,NA,Feature0133,4,11,0,6,0,1,0,0,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,546350.0225404274,23244305.235080365,42.54471360136238,5.410907975684502,9.774350828929856e-8,7.267017355421763e-7,Upregulated
Feature0132,(Â±)9-HpODE,C18 H32 O4,312.2302,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,(Â±)9-HpODE,18,32,0,4,0,0,0,0,1.7777777777777777,0.2222222222222222,-1.333333333333333,98.29999999999998,3,-1,-0.07142857142857142,0.0625,-1,Lipid,2226184.2136906856,14946379.338467611,6.713900514858434,2.7471511596473563,8.741830719584505e-4,0.0021508677022287056,Upregulated
Feature0131,"3,5-Dihydroxybenzoic acid",C7 H6 O4,154.02666,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of phenylpropanoids;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Superpathway of chorismate metabolism;Other,"3,5-Dihydroxybenzoic acid",7,6,0,4,0,0,0,0,0.8571428571428571,0.5714285714285714,0.2857142857142856,52.15714285714286,5,1,0.3333333333333333,0.6,1,Lignin,348972.5122124108,903141.818271995,2.5880027413800297,1.3718391455272054,0.3913778674869338,0.468011296085774,Upregulated
Feature0130,Adenosine,C10 H13 N5 O4,267.09685,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,Adenosine-peak2,10,13,5,4,0,0,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Lignin,49296144.19212447,291968320.9345793,5.922741539311386,2.5662651301832904,5.1452659818114744e-14,1.759680965779524e-11,Upregulated
Feature0129,1-Deoxy-L-mannitol,C6 H14 O5,166.08408,NA,NA,1-Deoxy-L-mannitol-peak2,6,14,0,5,0,0,0,0,2.3333333333333335,0.8333333333333334,-0.666666666666667,79.30000000000001,0,-5,-5,-0.7142857142857143,-5,Carbohydrate,953802.2449160544,302987726.7255694,317.66304633958566,8.31135346124433,1.6064834918480772e-11,1.373543385530106e-9,Upregulated
Feature0128,Methyl acetoacetate,C5 H8 O3,116.04739,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of coenzyme A biosynthesis II (plants);Superpathway of L-lysine degradation;Other,Methyl acetoacetate,5,8,0,3,0,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,6920378.423812771,23673163.499593824,3.420790316629988,1.7743296742814048,0.2156494141567488,0.30102897812901264,Upregulated
Feature0127,4-Hydroxy-2-methylbenzoic acid,C8 H8 O3,152.04741,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of phenylpropanoids;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,4-Hydroxy-2-methylbenzoic acid,8,8,0,3,0,0,0,0,1,0.375,-0.25,67.425,5,2,0.4,0.5384615384615384,2,Lignin,91797846.59514777,33002186.622024525,0.35950937681112166,-1.4758986950086466,0.5283411824421103,0.5913890210902151,Downregulated
Feature0126,4-Nitrophenol,C6 H5 N O3,139.02701,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,4-Nitrophenol,6,5,1,3,0,0,0,0,0.8333333333333334,0.5,0.6666666666666665,41.3,5,2,0.5,0.7142857142857143,1,Lignin,3700369.115260135,4373000.242143357,1.1817740625142843,0.24095424021304757,0.5367051520103038,0.5978930357899801,Upregulated
Feature0125,D-(â)-Erythrose,C4 H8 O4,120.04229,NA,NA,D-(â)-Erythrose-peak2,4,8,0,4,0,0,0,0,2,1,0,60.3,1,-3,-Inf,-0.5,-3,Carbohydrate,153562914.99832386,4988245.3199545685,0.032483398221562904,-4.94415362310917,9.350773909708869e-8,7.267017355421763e-7,Downregulated
Feature0124,Acrylic acid,C3 H4 O2,72.02115,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of L-threonine metabolism;Other,Acrylic acid-peak1,3,4,0,2,0,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,2,0,0,0.5,0,Tannin,318162372.24423915,16455496.878460899,0.05172043683980563,-4.273121729321844,1.5926796851409604e-6,7.565228504419562e-6,Downregulated
Feature0123,"1,5-Anhydro-D-fructose",C6 H10 O5,162.0528,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Fructose and mannose metabolism;Other,Superpathway of butirocin biosynthesis;Other,"1,5-Anhydro-D-fructose",6,10,0,5,0,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,258713044.6881686,13685979.205118055,0.05290022859734038,-4.2405822331152585,8.868193165747962e-7,4.595336458614853e-6,Downregulated
Feature0122,NA,C7 H8 O6 S,220.00407,NA,NA,Feature0122,7,8,0,6,1,0,0,0,1.1428571428571428,0.8571428571428571,0.8571428571428572,35.87142857142857,4,-2,-Inf,0,-3,Tannin,209894.2071451141,143792.76828985495,0.6850725908335396,-0.5456712296070191,0.4994019668461306,0.5655479227197903,Downregulated
Feature0121,Xylitol,C5 H12 O5,152.0685,Metabolic pathways;ABC transporters;Other,Other,Xylitol,5,12,0,5,0,0,0,0,2.4,1,-0.4000000000000003,71.7,0,-5,-Inf,-1,-5,Carbohydrate,13306027.788933227,520478963.35015374,39.116028585408635,5.2896879971053234,7.905300621678547e-8,6.577474891435658e-7,Upregulated
Feature0120,Gluconic acid,C6 H12 O7,196.05834,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Galactose metabolism;Carbon metabolism;Ascorbate and aldarate metabolism;Other,Superpathway of microbial D-galacturonate and D-glucuronate degradation;Other,Gluconic acid,6,12,0,7,0,0,0,0,2,1.1666666666666667,0.3333333333333335,50.8,1,-6,6,-1,-6,Carbohydrate,116251909.0994396,1228091.2986344865,0.01056405273812752,-6.564692780880943,0.08894989209577883,0.1428209535058984,Downregulated
Feature0119,NA,C27 H37 N O5,455.26725,NA,NA,Feature0119,27,37,1,5,0,0,0,0,1.3703703703703705,0.18518518518518515,-0.8888888888888893,85.63333333333334,10,5,0.1904761904761905,0.2765957446808511,4,Lignin,77482.84401021212,1467335.1545639618,18.937548993046374,4.243177715852283,0.002346303254632552,0.005349571420562219,Upregulated
Feature0118,Glyceraldehyde,C3 H6 O3,90.03168,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Galactose metabolism;Carbon metabolism;Fructose and mannose metabolism;Glucagon signaling pathway;Central carbon metabolism in cancer;Other,Superpathway of anaerobic sucrose degradation;Superpathway of microbial D-galacturonate and D-glucuronate degradation;Homolactic fermentation;Superpathway of coenzyme A biosynthesis II (plants);Other,Glyceraldehyde,3,6,0,3,0,0,0,0,2,1,0,60.3,1,-2,-Inf,-0.3333333333333333,-2,Carbohydrate,2769661977.379991,160533567.01132363,0.05796142934495678,-4.108763017180528,1.2803348449388852e-6,6.412301724422883e-6,Downregulated
Feature0117,D-(+)-Glucose,C6 H12 O6,180.06335,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;ABC transporters;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Galactose metabolism;Carbon metabolism;Biosynthesis of phenylpropanoids;Biosynthesis of plant hormones;Ascorbate and aldarate metabolism;Biosynthesis of terpenoids and steroids;Fructose and mannose metabolism;Glucagon signaling pathway;Central carbon metabolism in cancer;Phosphotransferase system (PTS);Other,Superpathway of anaerobic sucrose degradation;Chitin biosynthesis;Superpathway of scopolin and esculin biosynthesis;Homolactic fermentation;Superpathway of CMP-sialic acids biosynthesis;Superpathway of betalain biosynthesis;Other,D-(+)-Glucose,6,12,0,6,0,0,0,0,2,1,0,60.3,1,-5,-Inf,-0.6666666666666666,-5,Carbohydrate,5543549403.580542,290297363.1657295,0.05236669542048789,-4.25520662281249,2.2316965204945054e-9,5.4470897539881624e-8,Downregulated
Feature0116,L-Iditol,C6 H14 O6,182.07904,Metabolic pathways;ABC transporters;Galactose metabolism;Fructose and mannose metabolism;Phosphotransferase system (PTS);Other,Other,L-Iditol-peak3,6,14,0,6,0,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,182458670.40450665,2456568426.8602514,13.463697950961146,3.751002811134702,6.607182358189126e-8,6.276823240279669e-7,Upregulated
Feature0115,D-(+)-Maltose,C12 H22 O11,342.11635,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Galactose metabolism;Phosphotransferase system (PTS);Other,Superpathway of anaerobic sucrose degradation;Chitin biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Other,D-(+)-Maltose,12,22,0,11,0,0,0,0,1.8333333333333333,0.9166666666666666,0,60.3,2,-9,-9,-0.5384615384615384,-9,Carbohydrate,5967173005.81427,9818246.848194545,0.0016453766027276033,-9.247366451033844,2.145881446618997e-9,5.4470897539881624e-8,Downregulated
Feature0114,NA,C29 H30 O10,538.1839,NA,NA,Feature0114,29,30,0,10,0,0,0,0,1.0344827586206895,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Lignin,358101.74061188655,259588.89939900342,0.7249026462575838,-0.46414083933529815,0.47282787493238887,0.5390534712300026,Downregulated
Feature0113,NA,C29 H30 O10,538.18389,NA,NA,Feature0113,29,30,0,10,0,0,0,0,1.0344827586206895,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Lignin,356732.945468375,222749.34014532386,0.6244148262024511,-0.6794233015901033,0.3052837491418081,0.4000269816340934,Downregulated
Feature0112,MFCD12974029,C4 H11 N O4 S,169.04083,NA,NA,MFCD12974029,4,11,1,4,1,0,0,0,2.75,1,0.5,46.05,0,-4,3,-Inf,-6,Other,23682173.456774168,189266460.4725992,7.9919379366956065,2.99854537958064,5.877792568008431e-8,5.912367818408481e-7,Upregulated
Feature0111,Perillic acid,C10 H14 O2,166.09931,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Perillic acid,10,14,0,2,0,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Lignin,648170.2588755107,201706.18211403507,0.31119320788332455,-1.684117522545199,0.11305108145284105,0.1722667036310612,Downregulated
Feature0110,NA,C12 H23 N O14,405.11202,NA,NA,Feature0110,12,23,1,14,0,0,0,0,1.9166666666666667,1.1666666666666667,0.6666666666666665,41.3,2,-12,4.333333333333333,-1.5,-13,Carbohydrate,631538715.5269234,1202220.8059449452,0.0019036375385820552,-9.037025475696032,1.9355794516051156e-5,6.186618434102333e-5,Downregulated
Feature0109,MFCD00155202,C10 H12 O4,196.07357,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,MFCD00155202-peak1,10,12,0,4,0,0,0,0,1.2,0.4,-0.4000000000000003,71.7,5,1,0.16666666666666666,0.375,1,Lignin,5716308.942924225,1335196.057773266,0.23357660880558276,-2.098032290061,0.3361297114939833,0.4180231321125174,Downregulated
Feature0108,3-Allyl-2-hydroxybenzoic acid,C10 H10 O3,178.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Other,NA,3-Allyl-2-hydroxybenzoic acid-peak2,10,10,0,3,0,0,0,0,1,0.3,-0.4000000000000003,71.7,6,3,0.42857142857142855,0.5294117647058824,3,Lignin,6067569.716027085,563176.9568601327,0.09281755022485164,-3.4294585694600945,0.3136340464911724,0.4062986511362915,Downregulated
Feature0107,beta-D-Ethyl glucuronide,C8 H14 O7,222.0739,NA,NA,beta-D-Ethyl glucuronide-peak1,8,14,0,7,0,0,0,0,1.75,0.875,0,60.3,2,-5,-5,-0.3333333333333333,-5,Carbohydrate,915971777.6971517,972502.8049655693,0.0010617169967949696,-9.879385021091206,8.206568186979418e-9,1.321397015711352e-7,Downregulated
Feature0106,DL-Lactic Acid,C3 H6 O3,90.03169,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Galactose metabolism;Carbon metabolism;Fructose and mannose metabolism;Glucagon signaling pathway;Central carbon metabolism in cancer;Other,Superpathway of anaerobic sucrose degradation;Superpathway of microbial D-galacturonate and D-glucuronate degradation;Homolactic fermentation;Superpathway of coenzyme A biosynthesis II (plants);Other,DL-Lactic Acid,3,6,0,3,0,0,0,0,2,1,0,60.3,1,-2,-Inf,-0.3333333333333333,-2,Carbohydrate,768015797.8545129,9379847.975065498,0.012213092492717636,-6.355427636541467,1.4616367504999112e-6,7.040560122126332e-6,Downregulated
Feature0105,Gentisyl Alcohol,C7 H8 O3,140.04739,Microbial metabolism in diverse environments;Other,NA,Gentisyl Alcohol,7,8,0,3,0,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.4545454545454546,1,Lignin,16384751.114348842,16856063.06364668,1.0287652797414233,0.04091385844128472,0.9673144763565029,0.9758747814570029,Upregulated
Feature0104,NA,C10 H5 N2 O6 P,279.98865,NA,NA,Feature0104,10,5,2,6,0,1,0,0,0.5,0.6,0.7999999999999998,37.5,10,4,1,1,1,Condensed HC,1627195658.190317,99476371.65607339,0.061133626528174174,-4.031890037541496,2.4317094864773634e-7,1.5993166237985735e-6,Downregulated
Feature0103,NA,C28 H28 O10,524.16829,NA,NA,Feature0103,28,28,0,10,0,0,0,0,1,0.35714285714285715,-0.2857142857142856,68.44285714285714,15,5,0.2777777777777778,0.43478260869565216,5,Lignin,188219.05891884753,177263.49769831268,0.9417935607399969,-0.08651723625526461,0.584291415913817,0.6446053685242755,Downregulated
Feature0102,NA,C10 H3 N2 O5 P,261.97802,NA,NA,Feature0102,10,3,2,5,0,1,0,0,0.3,0.5,0.7999999999999998,37.5,11,6,1.5,1.2222222222222223,3,Condensed HC,16122008.281328212,43326977.103155434,2.6874429256642176,1.4262341159167797,1.1012305502448467e-5,3.766208481837375e-5,Upregulated
Feature0101,Phenylacetaldehyde,C8 H8 O,120.05755,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,Phenylacetaldehyde,8,8,0,1,0,0,0,0,1,0.125,-0.75,81.675,5,4,0.5714285714285714,0.6,4,Unsaturated HC,240232.9384616046,126290.96617863866,0.5257021247268439,-0.9276825290346663,0.015481614875758077,0.030429380962696907,Downregulated
Feature0100,Î´-Gluconic acid Î´-lactone,C6 H10 O6,178.04765,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Galactose metabolism;Carbon metabolism;Ascorbate and aldarate metabolism;Other,Superpathway of microbial D-galacturonate and D-glucuronate degradation;Other,Î´-Gluconic acid Î´-lactone,6,10,0,6,0,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,9080535.882747158,944075.639780692,0.10396695216792408,-3.265803081139326,0.07978549785592494,0.13055808740060446,Downregulated
Feature0099,NA,C18 H34 O18,538.17464,NA,NA,Feature0099,18,34,0,18,0,0,0,0,1.8888888888888888,1,0.11111111111111116,57.133333333333326,2,-16,-Inf,-0.7777777777777778,-16,Carbohydrate,9638796.238911718,355671.5052200034,0.03689999211562968,-4.760235681747676,0.04759572394173352,0.08304968157180033,Downregulated
Feature0098,"8-(3-Furyl)-10-methyl-6,15-dioxo-7,14-dioxatetracyclo[11.2.1.0~2,11~.0~5,10~]hexadec-3-yl acetate",C21 H24 O7,388.15237,NA,NA,"8-(3-Furyl)-10-methyl-6,15-dioxo-7,14-dioxatetracyclo[11.2.1.0~2,11~.0~5,10~]hexadec-3-yl acetate",21,24,0,7,0,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Lignin,95604.66808598035,87225.29675829578,0.9123539520042188,-0.13233446157754084,0.43242660831395785,0.5064722604225123,Downregulated
Feature0097,NA,C32 H36 O11,596.22573,NA,NA,Feature0097,32,36,0,11,0,0,0,0,1.125,0.34375,-0.4375,72.76875,15,4,0.1904761904761905,0.3584905660377358,4,Lignin,137961.9952394178,106382.38947426836,0.7710992385232867,-0.37501155159251653,0.42703598198775716,0.5018773396557146,Downregulated
Feature0096,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid",C14 H16 O6,280.09473,NA,NA,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid-peak2",14,16,0,6,0,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,7,1,0.125,0.3636363636363637,1,Lignin,13777595.285321446,165502.4722002208,0.012012435317834164,-6.379327527091297,0.335708838383601,0.4180231321125174,Downregulated
Feature0095,1-Deoxy-L-mannitol,C6 H14 O5,166.08409,NA,NA,1-Deoxy-L-mannitol-peak1,6,14,0,5,0,0,0,0,2.3333333333333335,0.8333333333333334,-0.666666666666667,79.30000000000001,0,-5,-5,-0.7142857142857143,-5,Carbohydrate,1218867.1538214236,73241670.05575393,60.089953056922376,5.909051889706856,2.7059389533838555e-10,1.001837893495133e-8,Upregulated
Feature0094,NA,C9 H17 N O6,235.10561,NA,NA,Feature0094,9,17,1,6,0,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,1633471.1652991723,48449517.42753125,29.660466898206717,4.890469402943754,1.03713920882672e-5,3.619404177742227e-5,Upregulated
Feature0093,(2E)-3-[4-(Sulfooxy)phenyl]acrylic acid,C9 H8 O6 S,244.00412,NA,NA,(2E)-3-[4-(Sulfooxy)phenyl]acrylic acid-peak1,9,8,0,6,1,0,0,0,0.8888888888888888,0.6666666666666666,0.6666666666666665,41.3,6,0,-0.5,0.4,-1,Tannin,150631.87291443528,171671.0119093437,1.1396725579244404,0.18861937972760723,0.6127765155585784,0.6674190073918274,Upregulated
Feature0092,L-Saccharopine,C11 H20 N2 O6,276.13221,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,Superpathway of L-lysine degradation,L-Saccharopine,11,20,2,6,0,0,0,0,1.818181818181818,0.5454545454545454,-0.18181818181818168,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,1389959.3516549363,44137733.13570385,31.75469346146839,4.988897938210076,8.830440659723204e-7,4.595336458614853e-6,Upregulated
Feature0091,L-Iditol,C6 H14 O6,182.07903,Metabolic pathways;ABC transporters;Galactose metabolism;Fructose and mannose metabolism;Phosphotransferase system (PTS);Other,Other,L-Iditol-peak2,6,14,0,6,0,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,918741.4981183561,54971812.66594604,59.83381917387206,5.902889247590311,6.832169950715904e-6,2.5770252649948403e-5,Upregulated
Feature0090,EPERVUDINE,C12 H18 N2 O5,270.12157,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,EPERVUDINE,12,18,2,5,0,0,0,0,1.5,0.4166666666666667,-0.16666666666666696,65.05000000000001,5,0,-0.4,0.06666666666666667,-2,Protein,13032355.423608368,205509.46891301573,0.015769173125890296,-5.986749176980049,0.28783921686985403,0.3845352037870706,Downregulated
Feature0089,"2,4,6-Trihydroxyacetophenone",C8 H8 O4,168.04223,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"2,4,6-Trihydroxyacetophenone-peak1",8,8,0,4,0,0,0,0,1,0.5,0,60.3,5,1,0.25,0.5,1,Lignin,434434.1716181014,398508.1885876904,0.9173039659919006,-0.12452821759543985,0.5923216994925704,0.6492757090591638,Downregulated
Feature0088,N-Acetyl-b-D-galactosamine,C8 H15 N O6,221.08996,Metabolic pathways;ABC transporters;Galactose metabolism;Phosphotransferase system (PTS);Other,Superpathway of CMP-sialic acids biosynthesis;Other,N-Acetyl-b-D-galactosamine,8,15,1,6,0,0,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,4251949.0883132,50455321.59696646,11.866398338504732,3.5688102128787778,2.3723144719211685e-5,7.512329161083699e-5,Upregulated
Feature0087,NA,C15 H31 O17 P,514.12992,NA,NA,Feature0087,15,31,0,17,0,1,0,0,2.066666666666667,1.1333333333333333,-0.13333333333333375,64.10000000000001,1,-16,5.666666666666667,-1.5454545454545454,-17,Carbohydrate,1150381.6515896467,4992028.15417126,4.33945390842514,2.1175135004630046,3.8572307591235e-6,1.551968140729691e-5,Upregulated
Feature0086,3-Allyl-2-hydroxybenzoic acid,C10 H10 O3,178.06298,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Other,NA,3-Allyl-2-hydroxybenzoic acid-peak1,10,10,0,3,0,0,0,0,1,0.3,-0.4000000000000003,71.7,6,3,0.42857142857142855,0.5294117647058824,3,Lignin,5426772.284212241,93550.20160220617,0.017238645128774936,-5.8582097995013624,0.33186282915328247,0.4174532400169051,Downregulated
Feature0085,NA,C6 H13 N O9,243.05903,NA,NA,Feature0085,6,13,1,9,0,0,0,0,2.1666666666666665,1.5,1.3333333333333337,22.29999999999999,1,-8,2.25,-9,-9,Carbohydrate,233379152.514316,13415014.976399424,0.05748163377864918,-4.12075512222342,8.267730105210535e-9,1.321397015711352e-7,Downregulated
Feature0084,6-Deoxy-3-O-methyl-beta-D-galactopyranose,C7 H14 O5,178.08412,NA,NA,6-Deoxy-3-O-methyl-beta-D-galactopyranose-peak1,7,14,0,5,0,0,0,0,2,0.7142857142857143,-0.5714285714285712,76.58571428571427,1,-4,-2,-0.3333333333333333,-4,Carbohydrate,609193660.0810965,4424618.966781733,0.007263074547086919,-7.10520389692672,3.2392188815299843e-4,8.456586698345456e-4,Downregulated
Feature0083,D-Raffinose,C18 H32 O16,504.16918,Metabolic pathways;ABC transporters;Galactose metabolism;Other,NA,D-Raffinose,18,32,0,16,0,0,0,0,1.7777777777777777,0.8888888888888888,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,18875333.727516666,2771137.126907378,0.14681261623828057,-2.7679521444016175,0.11333335765201395,0.1722667036310612,Downregulated
Feature0082,"7a-Hydroxy-3,6-dimethyl-5,6,7,7a-tetrahydro-1-benzofuran-2(4H)-one",C10 H14 O3,182.09428,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"7a-Hydroxy-3,6-dimethyl-5,6,7,7a-tetrahydro-1-benzofuran-2(4H)-one",10,14,0,3,0,0,0,0,1.4,0.3,-0.7999999999999998,83.1,4,1,0.14285714285714285,0.29411764705882354,1,Lignin,143482.14436426086,2472960.3110247175,17.23531748136246,4.107295968850371,4.558081894819789e-6,1.751532593290301e-5,Upregulated
Feature0081,9(S)-HpOTrE,C18 H30 O4,310.2145,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,9(S)-HpOTrE,18,30,0,4,0,0,0,0,1.6666666666666667,0.2222222222222222,-1.2222222222222223,95.13333333333333,4,0,0,0.125,0,Lipid,745693.4108996242,18664204.378165647,25.02932720787845,4.645547606572713,0.003112915882619139,0.006781001476788189,Upregulated
Feature0080,"4-(1,3-Benzodioxol-5-ylmethyl)-3-(3,4,5-trimethoxybenzyl)tetrahydro-2-furanol",C22 H26 O7,402.16802,NA,NA,"4-(1,3-Benzodioxol-5-ylmethyl)-3-(3,4,5-trimethoxybenzyl)tetrahydro-2-furanol",22,26,0,7,0,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Lignin,201186.40142674284,136108.95513813215,0.6765315854992959,-0.5637708034358081,0.24444618054084824,0.3381609157077224,Downregulated
Feature0079,Glycerol 3-phosphate,C3 H9 O6 P,172.01364,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Methanobacterium thermoautotrophicumÂ biosynthetic metabolism;Other,Glycerol 3-phosphate,3,9,0,6,0,1,0,0,3,2,-0.666666666666667,79.30000000000001,0,-6,1.75,4,-7,Other,7775387.686488601,68174505.13619068,8.76798789784572,3.132245806997115,1.9604558784412465e-6,8.655652172463724e-6,Upregulated
Feature0078,Glucose 1-phosphate,C6 H13 O9 P,260.02973,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;ABC transporters;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Galactose metabolism;Carbon metabolism;Biosynthesis of amino acids;Biosynthesis of phenylpropanoids;Biosynthesis of plant hormones;Ascorbate and aldarate metabolism;Biosynthesis of terpenoids and steroids;Fructose and mannose metabolism;Glucagon signaling pathway;Central carbon metabolism in cancer;Phosphotransferase system (PTS);Other,Superpathway of anaerobic sucrose degradation;Chitin biosynthesis;Homolactic fermentation;Superpathway of CMP-sialic acids biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Methanobacterium thermoautotrophicumÂ biosynthetic metabolism;Superpathway of butirocin biosynthesis;Other,Glucose 1-phosphate,6,13,0,9,0,1,0,0,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,2253776.091224337,4128232.315183471,1.8316958509134145,0.8731799669679821,0.05030202796155802,0.0873263632632124,Upregulated
Feature0077,NA,C6 H7 N3 O6 P2,278.98094,NA,NA,Feature0077,6,7,3,6,0,2,0,0,1.1666666666666667,1,0.6666666666666665,41.3,6,0,1,1,-5,Tannin,2021939.4971261069,675966.1459497522,0.3343157136553986,-1.580716928146415,0.06909252834761616,0.11526655948724256,Downregulated
Feature0076,Azelaic acid,C9 H16 O4,188.10484,NA,NA,Azelaic acid,9,16,0,4,0,0,0,0,1.7777777777777777,0.4444444444444444,-0.8888888888888893,85.63333333333334,2,-2,-0.4,0,-2,Protein,12805642.081231793,8546627.180561492,0.6674110619636637,-0.5833524963085993,0.006756088549419211,0.013919170384948013,Downregulated
Feature0075,L-Glutathione oxidized,C20 H32 N6 O12 S2,612.15171,Metabolic pathways;Biosynthesis of cofactors;Other,Other,L-Glutathione oxidized,20,32,6,12,2,0,0,0,1.6,0.6,0.7000000000000002,40.349999999999994,8,-4,-Inf,-1,-12,Amino Sugar,194673.55254774573,249829.07480115126,1.2833231403627776,0.35988448632809283,0.3720220009873747,0.4495813580836825,Upregulated
Feature0074,NA,C18 H22 O7 S,382.10881,NA,NA,Feature0074,18,22,0,7,1,0,0,0,1.2222222222222223,0.3888888888888889,-0.33333333333333304,69.79999999999998,8,1,0,0.25925925925925924,0,Lignin,75015.38726970227,7062240.894554856,94.14389702693973,6.556795668597283,0.02240821103843528,0.042340376658258926,Upregulated
Feature0073,N-Phenylacetylglutamic acid,C13 H15 N O5,265.0951,NA,NA,N-Phenylacetylglutamic acid,13,15,1,5,0,0,0,0,1.1538461538461535,0.38461538461538464,-0.1538461538461542,64.6846153846154,7,2,0.14285714285714285,0.3684210526315789,1,Lignin,1223988.3630452824,1656344.564844886,1.3532355493347188,0.43641298216712987,0.1176938064744174,0.1765407097116261,Upregulated
Feature0072,Pyruvic acid,C3 H4 O3,88.01606,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Degradation of aromatic compounds;Carbon metabolism;Biosynthesis of amino acids;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant hormones;Ascorbate and aldarate metabolism;Biosynthesis of terpenoids and steroids;Glucagon signaling pathway;Central carbon metabolism in cancer;Phosphotransferase system (PTS);Other,Superpathway of anaerobic sucrose degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of microbial D-galacturonate and D-glucuronate degradation;Homolactic fermentation;Methanobacterium thermoautotrophicumÂ biosynthetic metabolism;Superpathway of L-threonine metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of coenzyme A biosynthesis II (plants);Superpathway of aromatic compound degradation via 3-oxoadipate;Superpathway of chorismate metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of L-lysine degradation;Other,Pyruvic acid,3,4,0,3,0,0,0,0,1.3333333333333333,1,0.6666666666666665,41.3,2,-1,-Inf,0.3333333333333333,-1,Tannin,4282368.677793264,4540287.673155718,1.0602281155053097,0.08437470412952776,0.8123606890741335,0.8522311523415755,Upregulated
Feature0071,Phenylpyruvic acid,C9 H8 O3,164.04728,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Degradation of aromatic compounds;Biosynthesis of amino acids;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Other,Superpathway of scopolin and esculin biosynthesis;Superpathway of chorismate metabolism;Other,Phenylpyruvic acid,9,8,0,3,0,0,0,0,0.8888888888888888,0.3333333333333333,-0.22222222222222232,66.63333333333333,6,3,0.5,0.6,3,Lignin,2175924.9428231553,993044.6331028506,0.456378165238744,-1.1316983252926012,0.4728539221315813,0.5390534712300026,Downregulated
Feature0070,2-isopropylmaleic acid,C7 H10 O4,158.05784,Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis,2-isopropylmaleic acid,7,10,0,4,0,0,0,0,1.4285714285714286,0.5714285714285714,-0.2857142857142856,68.44285714285714,3,-1,-0.3333333333333333,0.2,-1,Lignin,1530056.0995072008,23260216.51746792,15.202198484721933,3.926208070770169,1.6036370989253764e-7,1.0772526012674032e-6,Upregulated
Feature0069,L-Serine,C3 H7 N O3,105.04262,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;ABC transporters;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Carbon metabolism;Biosynthesis of amino acids;Central carbon metabolism in cancer;Other,Methanobacterium thermoautotrophicumÂ biosynthetic metabolism;Superpathway of chorismate metabolism;Other,L-Serine,3,7,1,3,0,0,0,0,2.3333333333333335,1,0.6666666666666665,41.3,1,-2,3,-3,-3,Carbohydrate,11208096.553874558,18236503.110126432,1.6270829772448923,0.702287826798505,4.029638672612759e-4,0.0010361928015289953,Upregulated
Feature0068,NA,C8 H21 N8 O8 P,388.12197,NA,NA,Feature0068,8,21,8,8,0,1,0,0,2.625,1,1.75,10.424999999999995,3,-5,1.5555555555555556,2,-14,Other,381216208.2256258,197860274.12961596,0.519023771446021,-0.9461274789209351,1.2647314752515775e-4,3.4882110043228995e-4,Downregulated
Feature0067,Propylparaben,C10 H12 O3,180.07863,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of phenylpropanoids;Other,NA,Propylparaben,10,12,0,3,0,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Lignin,159273.6287404284,26657567.878233146,167.36962728260275,7.3868939342434805,2.5666907721054132e-8,2.926027480200171e-7,Upregulated
Feature0066,NA,C19 H32 O3 S,340.20729,NA,NA,Feature0066,19,32,0,3,1,0,0,0,1.6842105263157894,0.15789473684210523,-1.2631578947368425,96.3,4,1,0,0.09090909090909093,0,Lipid,4312501.879882658,3365361.2937439154,0.7803732931556394,-0.3577636896867271,0.3129491402056875,0.4062986511362915,Downregulated
Feature0065,3-Hydroxyvaleric acid,C5 H10 O3,118.06304,Metabolic pathways;Other,NA,3-Hydroxyvaleric acid,5,10,0,3,0,0,0,0,2,0.6,-0.7999999999999998,83.1,1,-2,-1,-0.14285714285714285,-2,Amino Sugar,1928387.431460623,6013199.144990127,3.1182526119429927,1.6407378065588436,0.05193956363089829,0.08926296865209656,Upregulated
Feature0064,D-Glucopyranuronic acid,C6 H10 O7,194.04263,Metabolic pathways;Microbial metabolism in diverse environments;ABC transporters;Biosynthesis of cofactors;Ascorbate and aldarate metabolism;Other,Superpathway of microbial D-galacturonate and D-glucuronate degradation;Other,D-Glucopyranuronic acid,6,10,0,7,0,0,0,0,1.6666666666666667,1.1666666666666667,0.6666666666666665,41.3,2,-5,5,-0.6,-5,Carbohydrate,4468989.261976411,2350272.0746669853,0.5259068520624678,-0.9271208010120087,0.09917917953868696,0.15488255434808648,Downregulated
Feature0063,APM,C7 H13 N O4,175.08439,NA,NA,APM,7,13,1,4,0,0,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,1408133.3500094402,359413.2668297612,0.2552409307167902,-1.970068395066809,0.061835472606201244,0.10366535113392562,Downregulated
Feature0062,D-Glucono-delta-lactone,C6 H10 O6,178.04772,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Galactose metabolism;Carbon metabolism;Ascorbate and aldarate metabolism;Other,Superpathway of microbial D-galacturonate and D-glucuronate degradation;Other,D-Glucono-delta-lactone-peak1,6,10,0,6,0,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,4320124.25114874,13848247.106327418,3.2055205594249077,1.6805586618417123,2.78523672698962e-4,7.384115973879457e-4,Upregulated
Feature0061,NA,C3 H9 N7 O11,319.03608,NA,NA,Feature0061,3,9,7,11,0,0,0,0,3,3.6666666666666665,11.333333333333332,-262.69999999999993,3,-8,1,1,-15,Other,1201795.7228041359,550249.4543299681,0.4578560598019749,-1.1270339778941416,0.18022358842103806,0.2557529760995644,Downregulated
Feature0060,NA,C9 H18 O10,286.09013,NA,NA,Feature0060,9,18,0,10,0,0,0,0,2,1.1111111111111112,0.22222222222222232,53.96666666666666,1,-9,9,-1,-9,Carbohydrate,1800156.9591533563,270213.91359578934,0.15010575173560167,-2.735948835840513,0.02772040344705441,0.05042754244091812,Downregulated
Feature0059,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03784,NA,NA,4-Hydroxy-3-nitrosobenzamide,7,6,2,3,0,0,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Lignin,3367593.6291567264,1010528.8034664559,0.30007444922013965,-1.736607613514358,0.3257926985925905,0.4157697494565084,Downregulated
Feature0058,NA,C11 H16 N2 O7,288.09583,NA,NA,Feature0058,11,16,2,7,0,0,0,0,1.4545454545454546,0.6363636363636364,0.36363636363636376,49.93636363636363,5,-2,-2,-0.09090909090909093,-4,Lignin,70679863.65355179,35264466.72317912,0.49893229698395175,-1.0030840336980462,4.433221625070679e-4,0.0011314640266971436,Downregulated
Feature0057,NA,C17 H32 O17,508.16405,NA,NA,Feature0057,17,32,0,17,0,0,0,0,1.8823529411764703,1,0.11764705882352944,56.94705882352941,2,-15,-Inf,-0.7647058823529411,-15,Carbohydrate,22597511.839290623,171464.34036902082,0.007587753093723056,-7.0421115505959895,5.812294213581305e-4,0.001461621044885887,Downregulated
Feature0056,NA,C7 H16 N O7 P,257.0665,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Feature0056,7,16,1,7,0,1,0,0,2.2857142857142856,1,-0.5714285714285712,76.58571428571427,1,-6,4,-3,-8,Carbohydrate,477179.13542086823,1103256.6349186096,2.3120387146549186,1.2091655556988992,0.010175936868702676,0.020715300054144733,Upregulated
Feature0055,"5,7-Dihydroxy-4-methylcoumarin",C10 H8 O4,192.04227,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of phenylpropanoids;Other,Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Other,"5,7-Dihydroxy-4-methylcoumarin",10,8,0,4,0,0,0,0,0.8,0.4,0,60.3,7,3,0.5,0.625,3,Condensed HC,2121732.4682151447,148677.0634631437,0.07007342616961253,-3.8349887526973774,0.34688745775850616,0.42674644083960106,Downregulated
Feature0054,Dichloroacetic acid,C2 H2 Cl2 O2,127.94324,Microbial metabolism in diverse environments;Other,NA,Dichloroacetic acid,3,2,0,2,0,0,0,2,0.6666666666666666,0.6666666666666666,0.6666666666666665,41.3,3,1,1,1,1,Condensed HC,3434762.6049360186,787691.4686195544,0.22932923151299628,-2.1245078347310615,1.9515053296363314e-6,8.655652172463724e-6,Downregulated
Feature0053,Uridine 5'-diphosphogalactose,C15 H24 N2 O17 P2,566.05509,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Galactose metabolism;Ascorbate and aldarate metabolism;Other,Superpathway of anaerobic sucrose degradation;Superpathway of scopolin and esculin biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Superpathway of betalain biosynthesis;Other,Uridine 5'-diphosphogalactose,15,24,2,17,0,2,0,0,1.6,1.1333333333333333,0.3999999999999999,48.9,6,-11,2.5,-2.6,-15,Carbohydrate,1398377.4863663865,7121463.551332155,5.092661760335487,2.3484199008421114,7.656467901141075e-11,3.740731460271782e-9,Upregulated
Feature0052,N-Acetylglucosaminitol,C8 H17 N O6,223.10559,NA,NA,N-Acetylglucosaminitol-peak1,8,17,1,6,0,0,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,213272.73719237835,2373329.4498183145,11.128142682754152,3.4761409179374994,6.845500893753398e-7,3.837969353546986e-6,Upregulated
Feature0051,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",C8 H15 N O7,237.08486,NA,NA,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",8,15,1,7,0,0,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,1250720.982889551,3040567.8652533623,2.4310520946316205,1.2815808089822032,0.060974591188925294,0.1027256659439037,Upregulated
Feature0050,NA,C8 H7 N3 O6 P2,302.98095,NA,NA,Feature0050,8,7,3,6,0,2,0,0,0.875,0.75,0.5,46.05,8,2,1,NA,-3,Tannin,20769147.157055758,579785.5965700684,0.027915715180105594,-5.1627786723964375,6.410788961101969e-7,3.6541497078281224e-6,Downregulated
Feature0049,NA,C7 H12 O8,224.05313,NA,NA,Feature0049,7,12,0,8,0,0,0,0,1.7142857142857142,1.1428571428571428,0.5714285714285716,44.014285714285705,2,-6,6,-0.6666666666666666,-6,Carbohydrate,1319449.2564855246,294962.34117422975,0.22354959065261007,-2.161333190760286,0.16513745674118113,0.2382996211201854,Downregulated
Feature0048,Adenosine,C10 H13 N5 O4,267.09688,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,Adenosine-peak1,10,13,5,4,0,0,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Lignin,1482525.0012940138,14190018.305578746,9.571520408217781,3.2587481108317085,1.3876189886014355e-8,1.8982627764067637e-7,Upregulated
Feature0047,3797,C8 H10 O4,170.05789,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,3797,8,10,0,4,0,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Lignin,552723.551462966,606750.7767611312,1.0977472828055983,0.13454596344396702,0.47048767944646575,0.5390534712300026,Upregulated
Feature0046,Threonine,C4 H9 N O3,119.0583,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;ABC transporters;Biosynthesis of plant secondary metabolites;Biosynthesis of amino acids;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,Threonine,4,9,1,3,0,0,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,10164207.93209318,14506110.017909043,1.4271756456404672,0.5131629013871721,0.0030905492518841318,0.0067754348983613665,Upregulated
Feature0045,NA,C11 H25 N O7,283.16316,NA,NA,Feature0045,11,25,1,7,0,0,0,0,2.272727272727273,0.6363636363636364,-0.7272727272727275,81.02727272727273,0,-7,-2.6666666666666665,-0.6923076923076923,-8,Other,7559328.790055673,258688.6234079616,0.03422111017955291,-4.868969626190667,0.0019219153174032848,0.004471394820081112,Downregulated
Feature0044,NA,C8 H9 N3 O5 P2,289.00169,NA,NA,Feature0044,8,9,3,5,0,2,0,0,1.125,0.625,0,60.3,7,2,1.5,-1,-3,Lignin,840422.0745760544,631518.4371703011,0.7514300924197721,-0.41228920233666305,0.4397205428724582,0.5097777141097651,Downregulated
Feature0043,NA,C7 H7 N3 O6 P2,290.98097,NA,NA,Feature0043,7,7,3,6,0,2,0,0,1,0.8571428571428571,0.5714285714285716,44.014285714285705,7,1,1,1,-4,Tannin,3095630.309559786,367155.64271176164,0.11860448632316595,-3.0757695127119646,0.025182645355476947,0.04706264869712085,Downregulated
Feature0042,NA,C19 H30 O16,514.15333,NA,NA,Feature0042,19,30,0,16,0,0,0,0,1.5789473684210529,0.8421052631578947,0.10526315789473673,57.3,5,-11,-3.6666666666666665,-0.2727272727272727,-11,Carbohydrate,31451192.9799255,244024.68025526527,0.007758837014895431,-7.009943864025883,7.725557772436267e-8,6.577474891435658e-7,Downregulated
Feature0041,NA,C16 H39 N7 O11 P2,567.2184,NA,NA,Feature0041,16,39,7,11,0,2,0,0,2.4375,0.6875,-0.375,70.9875,2,-9,4.5,-8.333333333333334,-18,Other,1776645.6693805202,824913.7793792484,0.46430967839911425,-1.1068407411142163,0.28340837782954215,0.3831053961174048,Downregulated
Feature0040,"Î±,Î±-Trehalose",C12 H22 O11,342.11632,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Galactose metabolism;Phosphotransferase system (PTS);Other,Superpathway of anaerobic sucrose degradation;Chitin biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Other,"Î±,Î±-Trehalose-peak2",12,22,0,11,0,0,0,0,1.8333333333333333,0.9166666666666666,0,60.3,2,-9,-9,-0.5384615384615384,-9,Carbohydrate,1338962666.715411,846656.929461867,6.323230292438162e-4,-10.627050616038128,4.437256161115857e-8,4.598610930610979e-7,Downregulated
Feature0039,NA,C13 H16 N7 O5 P S2,445.03926,NA,NA,Feature0039,13,16,7,5,2,1,0,0,1.2307692307692308,0.38461538461538464,1.076923076923077,29.6076923076923,10,5,2.5,-5,-5,Lignin,57836526.840023056,647020.0165973353,0.011187048253900258,-6.482026763935619,1.7816508710670537e-6,8.234116187904491e-6,Downregulated
Feature0038,(6-Hydroxy-1-oxo-1H-isochromen-3-yl)methyl hydrogen sulfate,C10 H8 O7 S,271.99907,Other,NA,(6-Hydroxy-1-oxo-1H-isochromen-3-yl)methyl hydrogen sulfate,10,8,0,7,1,0,0,0,0.8,0.7,0.7999999999999998,37.5,7,0,-0.5,0.4545454545454546,-1,Condensed HC,4631551.920944749,335599.38246586337,0.0724593803964973,-3.786683720482593,0.3496222804545662,0.4270386425552202,Downregulated
Feature0037,NA,C16 H26 N2 O10,406.15889,NA,NA,Feature0037,16,26,2,10,0,0,0,0,1.625,0.625,0,60.3,5,-5,-1.75,-0.2222222222222222,-7,Amino Sugar,4474546.521335568,760440.389312465,0.16994803511071505,-2.556834412927839,8.593183413009438e-5,2.44905727270769e-4,Downregulated
Feature0036,Linoleic acid,C18 H32 O2,280.24026,Metabolic pathways;Biosynthesis of plant secondary metabolites;Other,Other,Linoleic acid,18,32,0,2,0,0,0,0,1.7777777777777777,0.1111111111111111,-1.5555555555555554,104.63333333333333,3,1,0.0625,0.1176470588235294,1,Lipid,279249.5094709217,15121742.280430082,54.15136559802878,5.7589258153001355,3.0330685245836055e-7,1.92094339890295e-6,Upregulated
Feature0035,trimetaphosphoric acid,H3 O9 P3,239.89901,NA,NA,trimetaphosphoric acid,0,3,0,9,0,3,0,0,Inf,Inf,NA,NA,1,-8,0.9166666666666666,0.8666666666666667,-11,Other,17981244.066077095,24335614.739598487,1.3533888228295265,0.4365763789896586,0.07534031683239129,0.12447530607090734,Upregulated
Feature0034,Monomethyl phthalate,C9 H8 O4,180.04223,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Degradation of aromatic compounds;Biosynthesis of amino acids;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Other,Superpathway of scopolin and esculin biosynthesis;Superpathway of chorismate metabolism;Other,Monomethyl phthalate,9,8,0,4,0,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Lignin,909777.2859184707,1981155.4386201375,2.1776268426179173,1.1227567555112479,0.16100454834495775,0.23431300227223642,Upregulated
Feature0033,NA,C10 H6 S,158.01901,NA,NA,Feature0033,10,6,0,0,1,0,0,0,0.6,0,-0.4000000000000003,71.7,8,8,0.7777777777777778,0.7777777777777778,7,Condensed HC,54961664.29721061,993580.2250338482,0.018077695385295564,-5.789645420657079,9.625541007568208e-8,7.267017355421763e-7,Downregulated
Feature0032,3-[(2Z)-1-Oxo-2-buten-2-yl]pentanedioic acid,C9 H12 O5,200.06847,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,3-[(2Z)-1-Oxo-2-buten-2-yl]pentanedioic acid-peak1,9,12,0,5,0,0,0,0,1.3333333333333333,0.5555555555555556,-0.22222222222222232,66.63333333333333,4,-1,-0.25,0.2307692307692308,-1,Lignin,6390271.857713656,4900385.340244809,0.7668508397384668,-0.38298210868046045,0.14591877008227422,0.21326589473563154,Downregulated
Feature0031,1-(beta-D-ribofuranosyl)thymine,C10 H14 N2 O6,258.08519,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,1-(beta-D-ribofuranosyl)thymine,10,14,2,6,0,0,0,0,1.4,0.6,0.3999999999999999,48.9,5,-1,-1.5,0,-3,Lignin,14018575.890864663,1765925.8245709268,0.12597041513480048,-2.988843146479344,6.073645584254401e-7,3.5206555759576355e-6,Downregulated
Feature0030,Leucylproline,C11 H20 N2 O3,228.14735,NA,NA,Leucylproline,11,20,2,3,0,0,0,0,1.818181818181818,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,15232080.996029245,13448477.283002665,0.8829047906526012,-0.17967022378505595,0.43424798035756007,0.5068696562535343,Downregulated
Feature0029,"3,4-Dihydroxyphenylpropionic acid",C9 H10 O4,182.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,"3,4-Dihydroxyphenylpropionic acid",9,10,0,4,0,0,0,0,1.1111111111111112,0.4444444444444444,-0.22222222222222232,66.63333333333333,5,1,0.2,0.42857142857142855,1,Lignin,1111456.4425734505,1072298.972475379,0.9647692265767907,-0.051744204827134196,0.823490008012034,0.8560291268696524,Downregulated
Feature0028,4-Pyridoxic acid,C8 H9 N O4,183.0532,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,4-Pyridoxic acid,8,9,1,4,0,0,0,0,1.125,0.5,0.25,53.175,5,1,0,0.4,0,Lignin,6917389.468083585,24092100.22579538,3.482831252592451,1.8002605742896405,3.0075952318457676e-11,2.0571951385825054e-9,Upregulated
Feature0027,Succinic anhydride,C4 H4 O3,100.01606,NA,NA,Succinic anhydride,4,4,0,3,0,0,0,0,1,0.75,0.5,46.05,3,0,0,0.6,0,Tannin,1428609.800175704,1125432.4206311381,0.7877815345328877,-0.34413249406900265,0.26513733387193783,0.3612628214510069,Downregulated
Feature0026,"2-(Hydroxymethyl)-5-methoxy-4-methyl-1,3-benzenediol",C9 H12 O4,184.07352,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,"2-(Hydroxymethyl)-5-methoxy-4-methyl-1,3-benzenediol",9,12,0,4,0,0,0,0,1.3333333333333333,0.4444444444444444,-0.44444444444444464,72.96666666666667,4,0,0,0.2857142857142857,0,Lignin,489590.3758226378,262580.63419370214,0.5363271975117957,-0.8988146796379325,0.4721991012424096,0.5390534712300026,Downregulated
Feature0025,100-1,C31 H34 O10,566.21508,Biosynthesis of secondary metabolites;Other,NA,100-1,31,34,0,10,0,0,0,0,1.096774193548387,0.3225806451612903,-0.4516129032258061,73.17096774193547,15,5,0.23809523809523808,0.38461538461538464,5,Lignin,84254.7292494017,109300.14029482217,1.297258222399407,0.37546568012584625,0.1437310213427358,0.2109699969923418,Upregulated
Feature0024,2-Oxo-4-pentenoic acid,C5 H6 O3,114.03175,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,2-Oxo-4-pentenoic acid,5,6,0,3,0,0,0,0,1.2,0.6,0,60.3,3,0,0,0.42857142857142855,0,Lignin,43952076.294232,646448.576828751,0.01470803273322464,-6.087251897350663,2.2012749007420094e-8,2.6755168424170133e-7,Downregulated
Feature0023,2-Hydroxycaproic acid,C6 H12 O3,132.0787,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,2-Hydroxycaproic acid,6,12,0,3,0,0,0,0,2,0.5,-1,88.8,1,-2,-0.6666666666666666,-0.1111111111111111,-2,Protein,5472725.812410378,1182591.0450822166,0.21608812237596142,-2.2103083205161207,9.222220743924859e-6,3.319999467812949e-5,Downregulated
Feature0022,Caffeic acid,C9 H8 O4,180.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Degradation of aromatic compounds;Biosynthesis of amino acids;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Other,Superpathway of scopolin and esculin biosynthesis;Superpathway of chorismate metabolism;Other,Caffeic acid,9,8,0,4,0,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Lignin,2830300.9539677207,9221828.272774795,3.258250066957356,1.7040973333031353,0.0027634915488594794,0.006137104608506117,Upregulated
Feature0021,NA,C6 H15 N O9,245.07472,NA,NA,Feature0021,6,15,1,9,0,0,0,0,2.5,1.5,1,31.799999999999997,0,-9,2.5,-11,-10,Carbohydrate,2871322.570531529,32399844.096158896,11.283944349784829,3.496199550850157,2.2687131119910347e-8,2.6755168424170133e-7,Upregulated
Feature0020,NA,C27 H24 N6 O8,560.16569,NA,NA,Feature0020,27,24,6,8,0,0,0,0,0.8888888888888888,0.2962962962962963,0.37037037037037024,49.74444444444445,19,11,0.38461538461538464,0.5294117647058824,5,Lignin,165058.55576234774,172656.13508580448,1.0460296001522986,0.06492367700427527,0.6860506278953844,0.7332166085631922,Upregulated
Feature0019,4-Methylphenol,C7 H8 O,108.05753,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,4-Methylphenol,7,8,0,1,0,0,0,0,1.1428571428571428,0.14285714285714285,-0.8571428571428568,84.72857142857141,4,3,0.5,0.5384615384615384,3,Lignin,1082198.654862616,4601705.937895967,4.25218227468611,2.088203440977546,0.09571738238699731,0.15089657732221487,Upregulated
Feature0018,NA,C10 H3 N2 O4 P,245.98313,NA,NA,Feature0018,10,3,2,4,0,1,0,0,0.3,0.4,0.6000000000000001,43.2,11,7,1.3333333333333333,1.2,4,Condensed HC,871302.4132886564,3188759.8967423756,3.6597624981970087,1.8717500272549172,0.033161386497549405,0.05937798001131883,Upregulated
Feature0017,Dimethyl phthalate,C10 H10 O4,194.058,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of phenylpropanoids;Other,Superpathway of scopolin and esculin biosynthesis;Other,Dimethyl phthalate,10,10,0,4,0,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Lignin,916416.1212588539,412578.6802713585,0.45020888513463875,-1.1513335653871875,0.3211245789261017,0.414432475444252,Downregulated
Feature0016,Polygonolide,C12 H12 O4,220.07345,NA,NA,Polygonolide,12,12,0,4,0,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,7,3,0.375,0.5,3,Lignin,1322804.282395834,218855.6190672178,0.1654482238830005,-2.595548290749398,0.3320095943994099,0.4174532400169051,Downregulated
Feature0015,Ethylmalonic acid,C5 H8 O4,132.04231,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Superpathway of L-lysine degradation;Other,Ethylmalonic acid,5,8,0,4,0,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,3155434.4081354025,2605415.162407125,0.825691434336202,-0.27632535600677377,0.8563129222379017,0.8832373546423281,Downregulated
Feature0014,[3-(4-Methoxyphenyl)-2-oxiranyl]methyl hydrogen sulfate,C10 H12 O6 S,260.03538,NA,NA,[3-(4-Methoxyphenyl)-2-oxiranyl]methyl hydrogen sulfate,10,12,0,6,1,0,0,0,1.2,0.6,0.20000000000000015,54.599999999999994,5,-1,-0.6666666666666666,0.16666666666666666,-2,Lignin,63168.059569059966,3977308.677045725,62.96392043984569,5.976453467737762,4.9728847424947254e-5,1.5050677716222974e-4,Upregulated
Feature0013,NA,C10 H16 O8,264.08464,NA,NA,Feature0013,10,16,0,8,0,0,0,0,1.6,0.8,0,60.3,3,-5,-2.5,-0.16666666666666666,-5,Carbohydrate,40121428.55390397,240233.40529066487,0.005987658315005069,-7.383792388134236,1.8361661451666403e-8,2.415264698642273e-7,Downregulated
Feature0012,.alpha.-Glucoheptitol,C7 H16 O7,212.08956,NA,NA,.alpha.-Glucoheptitol-peak1,7,16,0,7,0,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,1200936.8186757532,23669614.844035838,19.709292342402996,4.300804072565878,1.520828950025294e-10,6.501543761358131e-9,Upregulated
Feature0011,2-Oxobutyric acid,C4 H6 O3,102.03169,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Carbon metabolism;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of L-lysine degradation;Other,2-Oxobutyric acid-peak2,4,6,0,3,0,0,0,0,1.5,0.75,0,60.3,2,-1,-1,0.2,-1,Carbohydrate,35329234.101403505,2000875.017859815,0.0566351088199879,-4.142159514499442,4.037281955580053e-7,2.4223691733480316e-6,Downregulated
Feature0010,2-Hydroxyvaleric acid,C5 H10 O3,118.06305,Metabolic pathways;Other,NA,2-Hydroxyvaleric acid,5,10,0,3,0,0,0,0,2,0.6,-0.7999999999999998,83.1,1,-2,-1,-0.14285714285714285,-2,Amino Sugar,7388587.105493742,2602972.1632846626,0.35229633570256447,-1.5051386257065755,1.6023411687979204e-5,5.169817733291404e-5,Downregulated
Feature0009,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid",C14 H16 O6,280.09471,NA,NA,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid-peak1",14,16,0,6,0,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,7,1,0.125,0.3636363636363637,1,Lignin,3568332.638490873,80430.28579435938,0.022540019090926212,-5.471367452331454,0.33031371100558127,0.4174532400169051,Downregulated
Feature0008,"Î±,Î±-Trehalose",C12 H22 O11,342.11636,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Galactose metabolism;Phosphotransferase system (PTS);Other,Superpathway of anaerobic sucrose degradation;Chitin biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Other,"Î±,Î±-Trehalose-peak1",12,22,0,11,0,0,0,0,1.8333333333333333,0.9166666666666666,0,60.3,2,-9,-9,-0.5384615384615384,-9,Carbohydrate,1322458674.5718522,3385138.1392179504,0.002559730753260697,-8.60979221715714,3.5900492761982175e-6,1.4792733162166149e-5,Downregulated
Feature0007,Cytidine,C9 H13 N3 O5,243.08554,Metabolic pathways;ABC transporters;Other,Other,Cytidine,9,13,3,5,0,0,0,0,1.4444444444444444,0.5555555555555556,0.6666666666666665,41.3,5,0,-3,-0.14285714285714285,-3,Lignin,18956976.96276462,618197.4320262952,0.032610549310713485,-4.938517446904609,2.9445583515658455e-6,1.2280962880920966e-5,Downregulated
Feature0006,D-(â)-Erythrose,C4 H8 O4,120.04223,NA,NA,D-(â)-Erythrose-peak1,4,8,0,4,0,0,0,0,2,1,0,60.3,1,-3,-Inf,-0.5,-3,Carbohydrate,1810944815.6102488,79953818.70792383,0.04415033413427407,-4.5014318333950705,1.9247188349058126e-8,2.437977190880696e-7,Downregulated
Feature0005,Thymidine,C10 H14 N2 O5,242.09031,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,Thymidine,10,14,2,5,0,0,0,0,1.4,0.5,0.20000000000000015,54.599999999999994,5,0,-0.6666666666666666,0.09090909090909093,-2,Lignin,145870871.92268267,88935536.16800685,0.6096867386598347,-0.7138599287154541,0.0019749902711767124,0.004563828869881322,Downregulated
Feature0004,2-Oxobutyric acid,C4 H6 O3,102.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Carbon metabolism;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of L-lysine degradation;Other,2-Oxobutyric acid-peak1,4,6,0,3,0,0,0,0,1.5,0.75,0,60.3,2,-1,-1,0.2,-1,Carbohydrate,426387588.62827754,2419122.3746663467,0.005673529059438277,-7.461537882342114,1.0891090968112875e-8,1.5519804629560846e-7,Downregulated
Feature0003,NA,C9 H16 O7,236.0896,NA,NA,Feature0003,9,16,0,7,0,0,0,0,1.7777777777777777,0.7777777777777778,-0.22222222222222232,66.63333333333333,2,-5,-2.5,-0.2727272727272727,-5,Carbohydrate,352779779.9006125,41371304.487900436,0.11727232354290783,-3.09206551970204,2.707617713970724e-9,5.4470897539881624e-8,Downregulated
Feature0002,L-Iditol,C6 H14 O6,182.079,Metabolic pathways;ABC transporters;Galactose metabolism;Fructose and mannose metabolism;Phosphotransferase system (PTS);Other,Other,L-Iditol-peak1,6,14,0,6,0,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,36084023.6298873,2292930.4619673803,0.06354420131983884,-3.9760957106311117,7.489765256113538e-8,6.567947993822642e-7,Downregulated
Feature0001,"L-Fucono-1,5-lactone",C6 H10 O5,162.05279,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Fructose and mannose metabolism;Other,Superpathway of butirocin biosynthesis;Other,"L-Fucono-1,5-lactone",6,10,0,5,0,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,25388918.48221952,16212726.406741794,0.6385749128343519,-0.6470722188356133,0.0010512944996615013,0.0025499483608810887,Downregulated
